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Diffusion-weighted magnetic resonance imaging (DWI) is a key neuroimaging technique. 
Multi b-value DWI data is composed of an unknown number of exponential components 
which represent water movement in various compartments, notably tissues and blood vessels. 
The bi-exponential model, Intravoxel Incoherent Motion (IVIM), is commonly used to fit the 
perfusion component but does not take account of the multi-component nature of the data. 
In this work, a new fitting method, the Auto-Regressive Discrete Acquisition Points 
Transformation (ADAPT) was developed and evaluated on simulated, phantom, volunteer and 
clinical DWI data. ADAPT is based on the auto-regressive moving average model, making no 
prior assumptions about the data. 
ADAPT demonstrated that it could correctly identify the number of components within the 
diffusion signal. The ADAPT coefficients demonstrated a significant correlation with IVIM 
parameters and a significantly stronger correlation with cerebral blood volume derived from 
dynamic susceptibility contrast MRI. A reformulation of the ADAPT method allowed the 
IVIM parameters to be mathematically derived from the diffusion signal and demonstrated 
lower bias and more accuracy than currently implemented fitting methods, which are 
inherently biased. ADAPT provides a novel method for non-invasive determination of 
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1.1 Effects of Neurovascular Damage on the Brain 
Neurovascular damage is the disruption of blood vessels that supply the brain and spinal cord. 
Acute disruption to blood vessels or blood flow can quickly impair the central nervous system 
and become life-threatening. Chronic damage to blood vessels leads to neurodegeneration and 
associated neurocognitive and neurological disability (1). Highly sensitive and rapid imaging 
techniques are crucial in our understanding, diagnosis and management of such cerebral 
conditions.   
Neurovascular injuries can present in a multitude of ways (2), dependent upon the 
injury/disease and site of vascular disruption. Neurovascular damage can be caused directly 
from injury, such as blunt force trauma (3) or radiation therapy (4), or from disease, such as 
stroke (5) or a brain tumour (6), and has been linked to dementia (7).  For acute conditions, 
imaging can provide rapid identification of the neurovascular condition, leading to a quick 
diagnosis, essential in the treatment of conditions such as strokes (8). For less acute 
conditions, non-invasive imaging techniques can diagnose and monitor the neurovascular 
damage, crucial for patient management.  
Imaging techniques can be implemented to obtain quantitative perfusion measurements. These 
measurements can aid in the understanding of different conditions, perhaps most clearly 
demonstrated in the assessment of brain tumours (9)(10). All current methods for measuring 
perfusion have significant limitations (11), and in this thesis, novel methods which address 
some of these limitations are developed and evaluated. These methods are developed with a 
specific focus on children who have brain tumours.  However, the techniques developed 
should apply to a variety of conditions. 
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1.2 Measuring Blood Perfusion with MRI 
Cerebral perfusion, the passage of fluid through the circulatory system, can be measured with 
a range of different modalities including Magnetic Resonance Imaging (MRI), Computed 
Tomography (CT) (12), Positron Emission Tomography (PET) (13) and Near-Infrared 
Spectroscopy (NIRS) (14).   
NIRS can provide continuous perfusion measurements through the assessment of the 
absorption of the near-infrared electromagnetic spectrum. However, due to its penetration 
depth, NIRS can only be used to scan cortical tissue (15), and spatial resolution is poor, only 
localised to the site of the source-detector measurements (16). PET is a long-established 
modality for measuring cerebral dynamics, in particular, Cerebral Blood Flow (CBF). 
However, PET uses radioactive tracers, requiring a cyclotron, and limits its repeatability or 
use in healthy volunteers (17).  Additionally, the invasive procedure is at risk of 
complications and is sensitive to noise (18). Hence this modality is only feasible in very 
specific settings (11). CT provides reproducible quantitative perfusion measurements (12) and 
is faster and more readily available than MRI. However, MRI provides a higher spatial 
resolution with greater sensitivity (19). With MRI, perfusion can be measured with high 
temporal and spatial resolution (20).  
With MRI, the most common method for estimating CBF requires the dynamic tracking of a 
paramagnetic bolus and is known as Dynamic Susceptibility Contrast (DSC) (21) (other bolus 
tracking techniques such as Dynamic Contrast Enhanced (DCE) (22) imaging are also 
commonly used and are further discussed in Section 2.3.4)  . Parameters such as Cerebral 
Blood Volume (CBV) and Mean Transit Time (MTT) can also be measured with DSC; the 
results can be visualised as parametric colour maps than can be interpreted qualitatively or 
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quantitatively (23). CBV is considered a robust parameter for the evaluation of brain tumours 
due to the direct relationship to the capillary size and density (24). DSC measurements can aid 
in the grading of tumours (25), provide useful hemodynamic information not available 
through standard MR imaging alone- aiding in diagnosis (26) and also in predicting patient 
outcome (27). However, the interpretation of perfusion measurements can be challenging, 
quantification of parameters can be difficult to determine (28), and post-processing results can 
be user-dependent (22). Poor signal to noise ratio measurements requires the implementation 
of quality control methods (29)(30). In addition, there is no consensus over the protocol to 
implement (31). For methods requiring a bolus, there are serious concerns over the potential 
toxicity of the contrast agents used (32). Hence alternative methods of measuring blood 
perfusion, which are non-invasive, are greatly desired. Arterial Spin Labelling (ASL) is a non-
invasive perfusion measurement technique that is gaining considerable attention (33). 
However, interpretation of ASL measurements can be difficult because of low signal to noise 
ratio levels (34) and the repeated use during examinations for some populations, such as 
children, is restricted due to high specific absorption rates (35). Another non-invasive 
technique for measuring perfusion effects is Diffusion-Weighted Imaging (DWI), which is 





1.3 Measuring Blood Perfusion with Diffusion-Weighted 
Imaging: Advantages and Limitations 
DWI is a non-invasive MR imaging technique that measures the random movement of water 
molecules within biological tissue. Intravoxel Incoherent Motion (IVIM) imaging is a DWI 
technique that requires multiple b-values (a parameter that is changed by varying the diffusion 
sensitization of the MR sequence) in order to measure diffusion and perfusion-related 
properties of biological tissue (36) (a comprehensive overview of the IVIM method is 
provided in the following chapter). IVIM-based perfusion measurements are gaining 
increasing acceptance, particularly in the field of oncology (37). The perfusion fraction, 
IVIM-f, has demonstrated clinical value in discriminating between high- and low- grade brain 
gliomas (38) and is prognostic for survival in brain gliomas (39). The pseudo-diffusion 
coefficient, IVIM-D*, which macroscopically describes the incoherent motion of blood within 
the capillary network (40), has additionally shown efficacy in the discrimination of low- and 
high- grade tumours (41). The IVIM method has demonstrated a moderate correlation to other 
perfusion methods (42). Furthermore, the IVIM methodology is fundamentally different from 
other perfusion techniques; hence, the measured perfusion information obtained could be 
complementary to these other perfusion methods. 
The IVIM method is confounded by some limitations. There is no consensus as to the number 
of data points ( b-values) or the distribution that should be used (43). Post-processing 
techniques, such as the fitting method implemented can also affect the estimated parameter 
values (44). The impact of these factors is most evident in the IVIM-D* parameter which has 
the greatest measurement error of the IVIM parameters (45). The IVIM method also assumes 
that two compartments, water diffusion and perfusion within the capillary bed, exist within 
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the diffusion signal. However, more compartments may be present, either due to signal 
mixing with other tissues (40) or additional perfusion effects (35). These challenges could 
potentially confound the use of some of the IVIM parameters as robust biomarkers. There is a 
need for a robust method which can fit multi b-value DWI without prior knowledge of the 
number of components and extract relevant information on the perfusion of the tissue.   
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1.4 Robust Biomarkers 
MRI is a popular diagnostic modality with most clinical data assessed by expert qualitative 
review (46). Qualitative assessment can be rapid but potentially challenging when qualitative 
features from multiple image types require consistent interpretation (47). In addition, the 
results from different reviewers of qualitative data can be highly varied. Hence there is a need 
for more robust measurements with quantitative biomarkers (48).   
Perfusion is a complex physiological process that can be measured by a multitude of different 
parameters, attained through a variety of imaging modalities. Although many different 
parameters could be complementary in their characterisation of perfusion, it is unfeasible that 
all will gain clinical use (49). Hence to ensure the implementation of robust biomarkers, a 
multitude of factors have to be considered. 
Imaging biomarkers are a subset of all biomarkers and can be either quantitative or qualitative 
(50). Quantitative Imaging refers to the extraction and use of numerical and statistical features 
from a medical image (51). As defined by the Quantitative Imaging Biomarkers Alliance, 
organised by the Radiological Society of North America (RSNA), a quantitative imaging 
biomarker is:  
“An objective characteristic derived from an In-Vivo image measured on a ratio or 
interval scale as indicators of normal biological processes, pathogenic processes, or a 
response to a therapeutic intervention.” (52) 
Several different groups associated with the development of quantitative imaging biomarkers 
(QIBs) (50) have issued consensus statements for guidelines for the acquisition and analysis 
of some QIBs. Technical validation, clinical validation and cost-effectiveness all have to be 
established for a potential QIB. 
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For the technical validation of a QIB, the robustness of the biomarker has to be validated. 
This is established through determining the QIB’s bias (accuracy), precision (variability), and 
determining its inherent reliability (confidence interval) in parameter measurements. In order 
to interpret the results from multiple studies, the acquisition protocol needs to be standardised 
(53). For DWI, this requires a consensus on factors such as magnetic field strength and 
maximum slice thickness (54).  
In the initial stages of biomarker discovery, the precision and bias of a parameter are 
considered (55) via computer simulations, before being validated in phantoms, preclinical or 
clinical datasets (52). QIBA recommend that quality control metrics such as parameter mean, 
standard deviation, coefficient of variation, bias estimate and noise estimation are 
implemented for technical validation (56).  
For imaging biomarkers, clinical validation occurs simultaneously alongside technical 
validation. Clinical validation of QIBs is conducted by assessing factors such as the 
sensitivity and specificity (57) of the new biomarker. Subsequent technical validation is then 
required by assessing multicentre reproducibility (58). At every stage in the development of a 
new QIB, the cost-effectiveness, i.e. the cost of scan time and assessment, has to be 




1.5 Project Aims and Objectives 
The overall aim of this work was to develop a new MR method to probe and understand 
multicomponent diffusion and perfusion within biomedical systems. The project focuses on a 
novel fitting method for DWI data. The method is validated by investigating if the number of 
components in the diffusion signal can be correctly determined. The model’s coefficients are 
investigated as potential imaging biomarkers with comparisons to DSC-MRI, the current 
standard for MR perfusion. 
1.5.1 Objectives 
1. To develop a new fitting model for multi- b-value DWI data based upon a modified version 
of the Auto-Regressive Moving Average (ARMA) model. Such a model will have the ability 
to fit a variable number of components. 
2. To investigate the performance of the new method to fit multicomponent data and 
determine the number of components. Compare the results to multiexponential fitting 
methods currently implemented. Explore computerised simulations modelling tissues with 
different water motions, including blood flow.  
3. To explore the biophysical origin of the perfusion effects measured with DWI. Compare 
the perfusion MR parameter cerebral blood volume (estimated using Dynamic Susceptibility 
Contrast) to perfusion related parameters obtained with DWI. 
4. To further develop the mathematical formalism of the new method. Compare the 
coefficients of the new method to the parameters of multi-exponential fitting methods. Derive 




1.6 Thesis Structure 
In Chapter 2, a background into MR physics and DWI is provided. Common diffusion 
models, such as the ADC and IVIM model are highlighted. The factors confounding image 
quality and the effects these have on biomarker reproducibility are considered. Some of the 
pitfalls of the IVIM model are highlighted, particularly in low perfused tissues such as the 
brain. The relation of perfusion parameters to the IVIM model and the success of correlation 
studies is discussed.  Multiexponential fitting methods, in general, are explored along with 
model selection techniques. Finally, the ARMA Model and its potential for modelling multi-
exponential data is introduced.  
In Chapter 3, the ARMA model is introduced as the ADAPT model, modified for DWI 
signals. A full mathematical formalism is provided and discussed. The methodology for using 
ADAPT to determine the number of components in the diffusion signal is presented. A partial 
volume effects model, combining white matter and cerebrospinal fluid signals is investigated 
and the results compared to those of multi-exponential fitting methods.  
In Chapter 4, the perfusion related measurements from DWI, including the ADAPT 
parameters, are explored. The correlation between the ADAPT(1,1)-α1 and DSC-CBV 
parameters is investigated and compared to the correlation between IVIM-f and DSC-CBV 
across a patient cohort. The ADAPT method is used to determine the number of components 
in the diffusion signal. The impact of the number of components upon the correlation strength 
is investigated.  
In Chapter 5, the IVIM parameters are fully derived from the ADAPT coefficients with a 
particular focus on IVIM-D*. The ADAPT fitting method is compared to the multi-step, non-
linear, least-square fitting algorithm commonly used to estimate the IVIM parameters. Both 
11 
 
fitting methods investigate simulated white matter and grey matter brain models, considering 
the accuracy, precision and bias for a range of Signal to Noise Ratio (SNR) levels. Once 













This chapter provides an overview of the fundamentals of MR physics and the phenomenon 
of diffusion. The methodology for attaining MR images sensitive to diffusion is explained. 
Modelling of the diffusion signal in order to gain clinically relevant biomarkers, also related 
to perfusion, is discussed. The challenges that different diffusion models encumber are 
explored and the desire for a novel fitting method established. 
2.1 MR Physics 
2.1.1 Magnetic Characteristics of the Nucleus 
The magnetic properties of a nucleus are affected by spin, an intrinsic quantum property of the 
particle’s angular momentum, and the electrical charge distribution of the protons and neutrons. 
Although neutrons have no overall electrical charge, the distribution of charge is 
inhomogeneous. This inhomogeneity, in addition to the nuclear spin, leads to the neutrons 
generating a magnetic field that is equal and opposite to that generated by the protons.  
The magnetic characteristics of a nucleus can be defined by the nuclear magnetic moment, a 
vector dictated by the pairings of constituent protons and neutrons. Individual protons and 
neutrons have an associated magnetic moment and spin ½. The angular momentum of nucleons 
tends to form pairs acting as single entities with intrinsic angular momentum. If the sum of the 
number of protons (P) and neutrons (N) are both even, then no magnetic moment is observed. 
However, if P is even and N is odd, large integer spins are associated with the unpaired nucleons 
and a magnetic moment is observed (59). If P is odd, a half-integer spin is observed associated 
with the odd proton.  
14 
 
Several elements present in biological tissue can generate a magnetic moment. Within 
biological tissues, hydrogen is the best candidate for generating such an MR signal due to its 
high isotopic abundance, a strong magnetic moment and being heavily concentrated in water 
and lipids (60). Although other elements, such as 23Na and 13C, have been used to image the 
body, the proton is primarily used to generate the MR signal. 
The spin of the proton can be considered as a spinning gyroscope that is electrically charged; 
this creates a loop of electrical current about the spinning axis which can interact with external 
magnetic fields as well as being capable of generating its own. If many unbound hydrogen 
atoms are considered then, due to their thermal energies, they will assume a random orientation 
of magnetic moments, resulting in no net magnetic moment being observable. Should an 
external magnetic field be applied, the magnetic moment vectors will align themselves as 
parallel or anti-parallel at two discrete energy levels to the field (Figure 2.1). 
 
Figure 2.1: A) Nuclei spins are randomly orientated. B) In the presence of a magnetic field, nuclei 
spins align either spin aligned or spin opposed to the magnetic field. 
 
 
A small majority of spins exist in the lower energy state; the energy gap between the two states 
depends upon the strength of the applied magnetic field (Figure 2.2). Increasing the magnetic 
field increases the number of spin protons in the lower energy state and thus creates an 
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observable magnetic moment, leading to the magnetisation, M0, of the nuclei that runs parallel 
to the magnetic field. 
Figure 2.2: Energy of the interactions between a hydrogen nucleus and the applied magnetic 
field, B0. Two possible spin states with two different energies are possible with the energy 
level dependent upon the magnetic field, the reduced Planck constant ћ, the gyromagnetic 
ratio γ and the spin energy state either ½ or -½. 
 
However, the axis of the nucleus does not perfectly align with the applied magnetic field due 
to its angular momentum, resulting in the nuclei having a transverse magnetic moment 
component.  This component has no fixed direction and can be at any angle perpendicular to 
B0. The angular momentum causes the nucleus to precess about the direction of B0. The angular 
frequency of this precession is known as the Larmor frequency, ω0, dictated by the Larmor 
equation:  
𝜔0 = 𝛾𝛽0 (2.1) 
Where γ is the gyromagnetic ratio, a specific constant determined by the element. For a 
hydrogen nucleus, a proton, γ is approximately 2.68 × 108 rad s-1 T-1. Due to the random 
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distribution of proton alignments, there is no net magnetisation across the nuclei in the 
transverse direction to the magnetic field. 
2.1.2 Applying a Radio Frequency Pulse 
The nuclei can be distributed from equilibrium by the introduction of a secondary magnetic 
field, B1. To excite those nuclei in the lower energy state, they must receive energy equal to the 
energy difference between the two energy states- hence B1 must oscillate with a frequency equal 
to that of ω0. By applying B1 perpendicular to B0, the net magnetisation M0 is rotated and begins 
to precess about the sum direction of B0 and B1. For imaging purposes, B1 is required to be 
rapidly switched on and off; so it has a much smaller magnitude than B0. The total magnetic 
field changes with time as B1 rotates and M0 precesses about the vector sum of these two fields 
(Figure 2.3).  
 
Figure 2.3: Precession of net magnetisation A) Stationary reference frame. B) Rotating reference 
frame- rotates at the Larmor frequency. M0 rotates around the B1 vector and appears stationary about 
B0. 
B1 is applied via a low energy radio frequency (RF) pulse. After the pulse, excited nuclei relax 
back to equilibrium and release detectable energy equal to that of the RF pulse. The number of 
excited nuclei, and therefore the size of the detectable signal, is dependent upon the magnitude 
and duration of the RF pulse. By applying B1 at ω0, M0 can be rotated away from B0. The angle 
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by which M0 rotates away from B0 is known as the flip angle. The rotating magnetisation 
induces an electrical signal in a receiver coil within an MRI scanner; this is the signal that 
creates the MR Image. This signal oscillates at the same frequency as ω0, its strength dependent 
on the angle of M0 from B0. The biggest change in signal is observed when M0 is perpendicular 
to B0, creating the largest fluctuation in the magnetic signal. Consequently, the MRI signal is 
dependent upon the magnitude of magnetisation and its flip angle. 
2.1.3 Relaxation 
Following the RF pulse, nuclei lose magnetic energy and magnetisation returns back to 
equilibrium, a process known as relaxation. The phenomenon can be expressed through two 
components with the longitudinal relaxation being a vector parallel to B0; this vector relaxes 
with time T1. In T1 relaxation the longitudinal component of M0 is recovered as energy is lost 
to the surrounding lattice; T1 is the time taken for the net magnetisation to recover from zero 
to (1-1/e) of the maximum value, approximately 63%. T1 relaxation is modelled by the 
equation: 
𝑀𝑧 = 𝑀0(1 − 𝑒
−𝑡 𝑇1⁄ ) (2.2) 
where t is time and M is the net magnetisation.  
For T1 relaxation to occur, the energy exchange from the nucleus to the surrounding material 
is stimulated through the interaction with another magnetic field close to the Larmor frequency. 
Typically, it is neighbouring protons that induce this relaxation. For molecules with unrestricted 
motion, such as pure water, a wide range of frequencies are possible. At any given time, only a 
small fraction of the water molecules will be at the rotational speed needed for the energy 
exchange. Consequently, water has a long T1. In fat, the water molecules interact with the long 
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carbon chains resulting in a lower resonant frequency. Fat molecules rotate slower than water 
molecules, resulting in a shorter T1. 
The transverse relaxation is the decay of the transverse component of M0, as energy is 
transferred between the spins, and has a relaxation time of T2.  T2 relaxation occurs at a much 
quicker rate than T1 and is modelled by:  
𝑀𝑥𝑦 = 𝑀0𝑒
−𝑡 𝑇2⁄  (2.3) 
T2 is the time taken for the transverse magnetisation to decay by (1/e), ~37%. T2 relaxation 
occurs via dipole-dipole interactions with other 1H nuclei. As the T2 signal is known to 
exponentially decay, by measuring at time t after relaxation the signal S(t) will be given by: 
𝑆(𝑡) = 𝑆0𝑒
−𝑡 𝑇2⁄  (2.4)  
Such that S0 would be the signal measured instantaneously after relaxation. Hence the signal 
detected is weighted by T2. 
Like T1, a tissue’s T2 is characterised, in part, by the speed of the molecular rotations. 
Consequently, moving water molecules have longer T1 and T2 values, whereas water with 
restricted movement, and lipids, have shorter relaxation times. Subtle differences in relaxation 
times amongst tissues allows for sensitive imaging. For example, white and grey brain matter 
can be readily distinguished on conventional MR images with relaxation observed via either 
the T1 or T2 signal.  
2.1.4 Magnetic Field Gradients 
To differentiate between all the MR signals generated from different locations, it is necessary 
to impose a spatially varying magnetic field gradient (Figure 2.4). This gradient varies linearly 
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and results in the total magnetic field being linearly dependent on the location within the 
scanner. The exact magnetic field strength at location ri:  
𝐵𝑖 = 𝐵0 + 𝐺𝑇 ∙ 𝒓𝒊 (2.5) 
Where GT is the gradient amplitude.  
 
Figure 2.4: Spatially varying gradient field, Gz, within the scanner. The gradient varies linearly and 
results in the total magnetic field being linearly dependent on its location within the scanner. 
This results in an additional term to the Larmor equations: 
𝜔𝑖 = 𝛾(𝛽0  + 𝐺 ∙ 𝒓𝒊) (2.6) 
Hence the resonant frequency of each proton is unique and varies as a function of location. 
By only exciting nuclei within a narrow range of frequencies, with an RF pulse that matches 
their Larmor frequency, selected spins can be isolated across a thin slice. This process is 




Figure 2.5: Slice selection with selective nuclei excitation. 
The thickness of the slice is determined by the magnitude of the slice selective gradient (Gss) 
and the range of frequencies within the RF pulse. The orientation of the slice is dependent upon 
the orientation of Gss (i.e. Gz). The slice selection process provides spatial resolution in the 
direction of Gss; the number of images created will be equivalent to the number of slices. To 
gain in-plane resolution in x and y- spatial encoding is required. This is done using two 
gradients: phase encoding and frequency encoding. These supplementary field gradients, whilst 
applied, temporarily change the resonant frequencies of the protons. Once switched off, the 
protons return to their original precessing frequencies but the phase induced remains. Phase 
encoding alters the phase of the voxels in the y-direction. This is done using another gradient 
and is similar to the process used for slice selection. The induced phase shift is proportional to 
the duration of the gradient and the position along the y-direction. After phase encoding, 
frequency encoding is performed where a frequency shift operator is used to change the angular 
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frequency of the spinning protons in the x-direction. The frequency encoding gradient, increases 
linearly in the x direction, predictably distorting the magnetic field such that the resonant 
frequency varies as a function of position. This is performed using a similar method to Gss and 
phase encoding. The bandwidth of these additional RF pulses will determine the resolution of 
the image. For each voxel in the image, we will have a specific phase and a specific angular 
frequency associated to the nuclei within that voxel (Figure 2.6). 
  





2.1.5 Creating an Image from the MR Signal 
When the RF pulse is switched off, both T1- and T2- relaxation occur. The transverse relaxation 
and dephasing caused by small variations in the magnetic field result in the MR signal decaying. 
To ensure that the signal is detected before it decays considerably, a signal echo is created by 
temporarily reversing the dephasing. Two possible techniques can create a signal echo: spin-
echo and gradient-echo. The spin-echo technique is executed by applying a subsequent 180° 
RF pulse after the initial 90° RF. As the signal begins to dephase after the 90° RF, the 180° RF 
pulse inverts the nuclei magnetisation and phase signal such that as the signal continues to 
propagate it becomes rephased. Spin echo allows more time for the signal to be detected (Figure 
2.7). 
 
Figure 2.7: Spin Echo: the effects of the pulse sequence on nuclei spin. 
 
The gradient echo technique works by applying a magnetic field gradient upon the nuclei and 
then rapidly applying another gradient in the opposite direction. The two field gradients cancel 
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out, and the transverse magnetisation is brought back in phase, creating a strong MR signal. 
The time from the peak of the first RF pulse to the middle of the echo is referred to as echo 
time- TE. The repetition time, TR, is the time between successive 90° RF pulses. For spin 
encoded images, the TE and TR are used to determine the image contrast. The detected signal 
S can be approximated by: 
𝑆 = 𝐾 ∙ [𝐻] ∙ (1 − 𝑒−𝑇𝑅/𝑇1) ∙ 𝑒−𝑇𝐸/𝑇2 (2.7)  
Where K is a scaling factor and [H] is the spin density. When TE is short relative to T2, the 
echo occurs before any substantial T2 relaxation has occurred. However, when TE is long, the 
T2 signal decays exponentially, and the contrast between different tissue types, exhibiting 
different T2 signals will be substantial. A T2-weighted image is acquired with a long TR and 
TE. If TR is long relative to T1, the signal will have time to fully recover from the RF pulse 
and will have no dependence on T1. 
However, if the repeating TR pulse is so rapid such that the nuclei haven’t fully relaxed-then 
the longitudinal magnetisation observed will be dependent upon T1. A T1-weighted image is 
acquired with a short TR and short TE. For the repeated RF pulse technique, the sensitivity of 
the signal can be controlled for different tissues by changing the interval time between repeated 
pulses.  
The attenuation in the signals leads to a decay in the voltage induced in the receiver. The signal 
measurements are stored in a large matrix known as k-space- an array of raw data representing 
spatial frequencies in the MR image. Each element contains information related to the whole 
image space with the kx and ky axes specifying the spatial frequencies in the (x,y) direction. K-
space is converted to image space using a Fourier transform.  
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To reduce the effects caused by patient movement, the slice can be acquired rapidly with a 
single, or a small number, of excitations. This mode of acquisition is referred to as Echo Planar 
Imaging (EPI). Different methods exist for acquiring k-space, but by applying the frequency 
encoding gradient, with an intermittent phase encoding gradient, all of k-space can be acquired 
with a rectangular zig-zag pattern (Figure 2.8).  
 
Figure 2.8: A) Image is acquired in k-space B) Using a zig-zag transversal C) Converted to image space 




2.1.6 Image Quality 
A multitude of factors affect MR image quality. The image resolution is determined by the size 
of the 3D voxel. The smaller the voxels, the greater the resolution. Image resolution can be 
increased by reducing the slice thickness and increasing the matrix size (number of voxels) 




× 𝑆𝑙𝑖𝑐𝑒 𝑇ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠 (2.8) 
 Increasing the matrix size increases spatial resolution in the xy plane but also increases the 
scan time due to more voxels needing to be acquired. The smaller voxels also result in a 
decreased signal due to there being fewer nuclei. Increasing the slice thickness will increase the 
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signal intensity but result in a poorer resolution in the z plane. Thicker slices can also result in 
partial volume effects, where the signals from different tissue types mix. 
A high image resolution is desirable for improved image quality and enables the delineation of 
tissue structures and small pathologies. However, image resolution is inversely proportional to 
the signal to noise ratio (SNR) level. An MR image is created from the MR signal, containing 
useful information, and noise, signals containing no useful information. The noise causes static 
fluctuations in the image intensity and arises from electrical resistance, within the MR 
hardware, and electromagnetic noise, from the movement of charged particles within the 
subject. For the signal coming from the biological tissue to be distinguishable from the 
background noise, the SNR level needs to be sufficiently high. If the image resolution is too 
high, the poor SNR level will cause image graining (61) and the scan time will be unacceptably 
long. 
SNR levels can be improved by increasing the number of signal averages (NSA). If the slice 
acquisition is rapidly repeated, the amount of signal detected can be increased. An image can 
be calculated from the average of the acquired signals, reducing the effects of artefacts. 
Doubling the NSA improves the SNR by √2. Increasing the NSA greatly increases the scan 
time; doubling the NSA would double the acquisition time. Hence, for a clinically realisable 
scan, there still needs to be a trade-off between image resolution and SNR. 
The MR hardware also impacts image SNR. Given Faraday’s law of induction (62), the voltage 
generated in the receiver coil is proportional to the B0 field strength. In theory, the SNR of the 
MR Signal is proportional to B0. Clinical 3T MRI systems are becoming commonplace, with 
the added value of 3T over 1.5T well documented (63)(64). Hardware developments will 
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continue to improve SNR over the coming decades, with 7T for clinical use recently approved 
(65). 
Localised RF coils are the receivers, and sometimes transmitters, of the B1 field. The SNR level 
is greatly improved when the coil is as close to the anatomy of interest as possible. Hence there 
are a range of dedicated coils for different regions of the body. For MR imaging of the brain, a 
dedicated head coil is used. The RF coil is comprised of multiple channels, where the output of 
each channel provides a partial view of the overall image. The more channels there are, the 
better the image quality and the faster the acquisitions (66). However, to increase the number 
of channels, multiple small coils are required. The smaller the coil, the shorter the penetration 
depth (67); thus, many channels are suitable for cortical imaging but not for imaging deep brain 
structures. Consequently, a compromise is required, and 32-channel head coils are currently in 
routine use. 
A common technique implemented in MR protocols is parallel imaging. By using the known 
sensitivities and locations of the receiver coils, the spatial location of the MR signals can be 
informed. This enables the number of phase encoding steps to be reduced- greatly decreasing 
the scan time. However, such a technique also reduces the SNR. SENsitivity Encoding 
(SENSE) is a widely used parallel imaging technique which still observes a degradation in SNR 
but attempts to suppress the artefacts created by the subsampling (68). 
The receiver bandwidth is the range of frequencies collected during frequency encoding of RF 
pulse and is an adjustable parameter. Reducing the bandwidth increases SNR. However, if the 




Another method for increasing SNR is the addition of slice gaps. The slice profiles generated 
by the RF pulses are not perfect rectangles. Exciting once slice can cause partial excitation in 
the neighbouring slice. This interference is known as cross-talk and reduces the SNR (70). By 
introducing a small gap between neighbouring slices, the effects of cross-talk can be avoided. 
This is at the expense however, of the information on the slice gaps not being acquired. 
MR hardware developments have led to significant SNR improvements over the past decades 
(48). Future developments in scanner hardware and technology will undoubtedly continue this 
trend. 
TE and TR also affect SNR. A long TR ensures the longitudinal magnetisation to approach its 
maximum, increasing the signal and thus the SNR. However, the TR cannot be too long if T1-
weighting is desired. A long TR would also increase scan time. A short TE, ensuring the 
transverse decay is rapid, can also increase the SNR. However, a short TE is only an option for 
T1-weighted images due to the reduction in T2 effects. Hence changes to TE and TR for SNR 
improvement need to be mindful of the sequence being implemented. 
2.1.7 Measuring SNR 
It is important to know the SNR of an MR image when clinically relevant biomarkers are being 
calculated. The SNR can have a profound impact on the variance of a calculated parameter. It 
is paramount that the robustness of a parameter at relevant SNR levels is investigated before 
clinical implementation. Hence the SNR of the MR Image should be reliably measured. 
Magnitude images are most commonly acquired in MRI; the problems of phase artefacts are 
avoided by discarding the phase information. The noise in the real and imaginary parts of the 
MR signal is assumed to have a Gaussian distribution with zero mean (71). The noise is 
assumed to be uncorrelated between real and imaginary voxels (72). However, the magnitude 
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image is generated through a non-linear transformation, calculating the magnitude from the real 
and imaginary images. This non-linear mapping means the noise distribution is no longer 
Gaussian, instead governed by a Rician distribution (73). However, for the SNR attained in MR 
Images, the Rician noise can be well approximated by a Gaussian distribution (71)(74).  
Conventionally, the SNR can be calculated from the quotient of the mean pixel intensity, S, 
taken from a region of interest (ROI) within the desired tissue, and the standard deviation, σ, 
from a ROI (or multiple ROIs), drawn in the background of the image.  




The 0.655 term is due to the Rician distribution; all noise terms are positive, so σ is reduced. 
This method for measuring SNR assumes that the noise is distributed homogeneously across 





R is the acceleration factor, which quantifies the reduction in the number of phase encoding 
steps; g is the geometric/g factor characterising the specific geometry of the RF coil array (76). 
g is not a constant but a spatially dependent parameter.  Hence the SNR is locally dependent.  
For SENSE images, SNR can be measured using the National Electrical Manufacturers 
Association (NEMA) method (77). If a slice is successively imaged twice, with the same 
protocol, the locally dependent noise can be calculated from the difference between the two 
images. SNR can be calculated from the quotient of the mean pixel intensity, from a ROI drawn 
on both images, and the standard deviation of the ROI, drawn in the same location, of the 









(𝑆(𝑟, 𝑛1) + 𝑆(𝑟, 𝑛2))
1
√2
𝑠𝑡𝑑𝑑𝑒𝑣(𝑆(𝑟, 𝑛1) + 𝑆(𝑟, 𝑛2))
 (2.11) 
 
Where S is the signal intensity, r=(x,y,z) is the position within the ROI, and n is the repetition 
number. The NEMA method requires multiple acquisitions. For time-sensitive scans, where 
only one acquisition is obtained, measuring SNR for parallel imaging is problematic. However, 
if NSA ≥ 2 and presuming the data from each of the acquisitions can be individually accessed, 
this is not an issue.  
If multiple acquisitions are obtained, the noise of a single-pixel can be expressed by the 
stochastic variations in signal intensity. The SNR of the ROI can be calculated from the pixel-





𝑚𝑒𝑎𝑛(∑ 𝑆(𝑟, 𝑁)𝑁𝑛=1,…,𝑁 )
𝑠𝑡𝑑𝑑𝑒𝑣(∑ 𝑆(𝑟, 𝑁)𝑁𝑛=1,…,𝑁 )
 (2.12) 
For all of these methods, the SNR measured is dependent upon the location of the ROI. SNR is 
tissue and sequence-dependent. For example, on a T2-weighted image of the brain, grey matter 
appears brighter than white matter with a greater signal intensity and thus a higher SNR. The 
size of the ROI should be large enough to ensure that the variations in signal intensity are 
sufficiently measured. However, this can be restricted by the anatomy of the structure of 
interest. To ensure that the reported SNR is not biased to the ROI, multiple ROIs (~5) should 
be considered across the tissue of interest. Additionally, SNR measurements are dependent 
upon how they are defined and quantified. Hence, the methodology for measuring SNR, the 




2.2 Diffusion-Weighted Imaging (DWI) 
2.2.1 The Physics of Diffusion 
Molecules within biological tissue can have active movement, such as bulk flow. Alternatively, 
the movement of molecules can arise from diffusion- purely random translational motion. Due 
to the thermal energy of the molecules, they can randomly move around and collide with one 
another, with no overall net direction of flow. This phenomenon is known as Brownian Motion 
(78), where the movement of particles is governed by a Gaussian distribution. Diffusion is 
defined as the net movement of molecules from an area of high concentration to an area of low 
concentration. The mechanisms of diffusion are described by Fick’s first law (79): molar flux 
due to diffusion is proportional to the concentration gradient.  From this law, the parameter D 
arises, the diffusion coefficient (mm2/s). D measures the average area a group of particles will 
move in unit time.  
The diffusion of water molecules in biological tissue is an interesting phenomenon to observe. 
For free water at 37°C, that is no barriers interfere with its motion, Gaussian motion is assumed, 
the diffusion coefficient is 3 × 10-3 mm2/s (80). Unconstrained water molecules freely diffuse 
via Brownian Motion. However, in tissue, the movement of water molecules is restricted by 
cell membranes and macromolecules resulting in a smaller diffusion coefficient (Figure 2.9). 
The restriction is characteristic of the environment in which the water molecules reside (81). 
For tissues with strongly defined membranes and high cellular density, as typical with higher-
grade tumour tissue, water molecules are restricted both within and around the cells. In 
comparison, tissues with a low cellular density and with poorly defined membranes allow for a 
greater level of diffusion. This enables a particular tissue type to be identified by the degree of 




Figure 2.9: A) Movement of water molecules in tissue. B) Distribution of water molecules in 
unrestricted water follows a Gaussian distribution. The movement of water molecules in tissue is 
hindered, resulting in a restricted diffusion. 
 
 
2.2.2 Measuring Diffusion with MR 
By measuring the diffusion coefficient with MR, the structural environment of tissue can be 
probed non-invasively. The sensitivity of MR to diffusion was first documented by Hahn (1950) 
(83) with the spin-echo sequence (2.1.3). Most diffusion sequences are based upon the pulse 





Figure 2.10: Pulsed Gradient Spin Echo (PGSE) sequence 
In this sequence, diffusion sensitive gradients are applied either side of the 180° refocusing RF 
pulse. Stationary spins, those not undergoing diffusion, will be unaffected as any phase shift 
induced by the first gradient will be reversed by the second. However, any spins that move will 
not fully rephase, there will be a net phase shift, and the signal will attenuate. It should be noted 
that the detected movement of spins is not just due to diffusion processes but could be a result 
of any movement of comparable magnitude. 
The diffusion sensitive gradients are known as b-values and are dependent upon the magnitude 
of the gradient, G, the duration of each gradient pulse, δ, and the time interval between the two 
gradient pulses, Δ- encapsulated by: 
𝑏 = 𝛾2𝐺2𝛿2(∆ − 𝛿 3⁄ ) (2.9) 
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The larger G and δ are, the more dephasing happens. The larger Δ is, the more time there is for 
diffusion. The duration of the pulses needs to be rapid to minimise the diffusion that occurs 
during the pulses (85). The greater the b-value, the greater the sensitivity to diffusion and the 




= 𝑒𝑥𝑝−𝐷∙𝑏 (2.10) 
S(0) is the detected signal with b-value= 0 s/mm2 (no diffusion weighting) and S(b) is the 
attenuated signal at a particular b-value. S(0) and S(b) are weighted equally by M0, T1 recovery 
and T2 decay (86). By dividing S(b) by S(0), relaxation effects are removed, and the signal is 
only influenced by diffusion effects. To ensure that the signal is diffusion-weighted, the effects 
of T1 are reduced by making TR long. TE is kept as short as possible, but this is limited in order 
to fit the diffusion gradients into the sequence. Consequently, there are some T2 effects in the 
diffusion image. This results in some areas on the diffusion image being bright solely due to T2 




2.3 Modelling of DWI 
For the diffusion signal to be correctly interpreted, an accurate biophysical model is required 
such that the model’s diffusion parameters can relate to the structural features and phenomena 
on a cellular level (88). This section will focus on isotropic, multi b-value, diffusion models. 
Some of these models are biophysically motivated, relating multicomponent behaviour to the 
tissue structure. Others are data-driven and employ statistically motivated models that ensure 
an optimised fit and the error in the fitting parameters minimised. 
2.3.1 Apparent Diffusion Coefficient (ADC) 
The Apparent Diffusion Coefficient model is the simplest of the diffusion models, assuming 
monoexponential behaviour. To obtain the diffusion coefficient, two b-values are required. 
These are typically b-value=0s/mm2 and b-value=1000s/mm2 (89). The large difference in b-
values enables a large signal attenuation. The apparent diffusion coefficient (90) is calculated 




= 𝑒𝑥𝑝−𝑏∙𝐴𝐷𝐶 (2.11) 
Where ADC is the apparent diffusion coefficient. It is ‘apparent’ in order to emphasise that the 
results differ from Gaussian diffusion observed in free water. For each voxel in an image, the 
ADC can be established from the two diffusion images. (Figure 2.11). By plotting the attenuated 




Figure 2.11: Modelling the diffusion signal with the Apparent Diffusion Coefficient model with b-
values=0 and 1000s/mm2. 
 
Both theoretical and experimental studies have suggested that the water diffusion in tissue is 
characterised by multi-component behaviour (92)(93). Despite being a simplified 
monoexponential diffusion model, ADC is still the most commonly used model for DWI 
analysis (94). Requiring only two b-values, it is quick and relatively easy to interpret with most 
vendors providing software that automatically generates an ADC map from the raw data (95).  
Acquiring an ADC map is routine in most MR protocols. Despite the oversimplification of the 
model, the ADC provides a robust biomarker (96), and its clinical value is evident, particularly 
in differentiating some human brain tumours (97).  
The ADC parametric maps can be assessed qualitatively by simply comparing the signal 
intensities of different regions for tissue characterisation (98). The ADC maps do however 
provide quantitative information. This can be assessed on a pixel-wise basis, but typically a 
mean value is taken from an ROI drawn on the ADC map (99). These quantitative values can 
be used to grade tumours, where higher grade tumours typically have a greater cellular density 
and consequently, a lower ADC value (100). In the healthy brain, the cerebral spinal fluid (CSF) 
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has an ADC comparable to that of free water ~ 3 × 10-3 mm2/s. Cortical Grey Matter has a 
typical  ADC of 0.78 - 1.09 × 10-3 mm2/s and White Matter 0.62 - 0.79 × 10-3 mm2/s (101). 
2.3.2 Intravoxel Incoherent Motion (IVIM) Model 
Only two b-values are required to calculate the ADC. However, when multi b-value DWI is 
performed, that is more than two b-values are acquired, it can be seen that plotting a straight 
line through the signal intensities no longer explains the behaviour observed, particularly at the 
low b-values (> 200s/mm2) (102). The signal attenuation is more than expected (Figure 2.12).  
 
Figure 2.12: Modelling the diffusion signal with the Intravoxel Incoherent Motion Model. 
 
 
This effect is theorised to be due to the bulk movement of water molecules within intravascular 
compartments, in particular, the movement of blood in the micro-capillaries; a phenomenon 
known as perfusion. A method which takes this perfusion into consideration was proposed by 
Le Bihan et al. (90) in 1986, known as the Intravoxel Incoherent Motion (IVIM) Method. 
Mathematically, the IVIM model is a bi-exponential equation which gives the relationship as: 
𝑆(𝑏)
𝑆(0)
= 𝑓 ∙ 𝑒𝑥𝑝−𝑏∙𝐷
∗
+ (1 − 𝑓) ∙ 𝑒𝑥𝑝−𝑏∙𝐷 (2.12) 
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where D is the diffusion coefficient, D* is the pseudo diffusion coefficient (the diffusion 
affected by perfusion) and f the flowing vascular volume fraction (the component of the 
signal attributed to perfusion) (90). The water flowing in the microcapillaries exhibits a 
random walk such that there is no coherent flow in any given direction (Figure 2.13). 
 
Figure 2.13: Water flowing in the capillaries mimics a random walk (Pseudo-diffusion) 
 
The IVIM parameters have demonstrated their clinical value in the management of acute strokes 
(103), and in the detection, diagnosing, staging and monitoring across a range of cancers 
(104)(105). IVIM-f has been shown to provide added value, distinguishing between high and 
low-grade gliomas (38) and also differentiating different grades of pancreatic cancer (106). In 
some cases, the IVIM parameters have demonstrated a greater sensitivity to pathology than the 
ADC model. IVIM-D* was shown to significantly decrease for mild and severe cases of renal 
dysfunction in the kidneys- the ADC only decreased significantly in severe renal dysfunction 
(107). For the characterisation of liver lesions, IVIM-D and IVIM-f provided more 
discriminatory power than ADC (108). 
38 
 
The IVIM parameter values for different organs differ significantly depending on the perfusion 
of the tissue (Table 2.1). 
Table 2.1: Typical IVIM parameters for Volunteers 
Study Organ 
IVIM-D 




(× 10-3 mm2/s) 
Number of 
Volunteers 
b-value sequence (s/mm2) 
A. Luciani et 
al. (109) 
Liver 1.10 ± 0.5 0.30 ± 0.05 80 ± 20 25 
10 [0, 10, 20, 30, 40, 50, 100, 
200, 400, 800] 
Y. Deng 
et al.(110) 
Kidney 1.85 ± 0.13 0.24 ± 0.04 14.53 ± 6.50 12 
9 [0, 50, 100, 150, 200, 300, 
400, 600, 800] 




0.77 ± 0.04 0.07 ± 0.01 7.9 ± 0.9 
18 
12 [0, 15, 30, 45, 60, 100, 




0.84 ± 0.05 0.14 ± 0.02 8.2 ± 0.9 
 
In high perfused tissues, such as the liver and kidneys, the volume fraction is high ~30%. The 
IVIM-D* parameter is considerably large, with the IVIM-D*/IVIM-D ratio reported as 70 in 
the liver (45). In low perfused tissue, such as the brain, the perfusion effects are more subtle 
with the IVIM-D*/IVIM-D ratio of 10 (45) and the volume fraction less than 10% (112). 
2.3.3 Challenges of IVIM 
2.3.3.1 Selection of b-values 
For the effects of perfusion to be measured from the diffusion signal, additional b-values are 
required, with a particular emphasis on sampling the signal between 0s/mm2 and 200s/mm2. 
There is, however, no consensus on the number of b-values that should be used in the 
diffusion sequence, nor their distribution. Studies have reported the use of between 5 and 16 
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b-values for IVIM measurements in the abdomen (109,113,114). Typically, between 6 and 8 
b-values are used in the abdomen, with at least four b-values between 0s/mm2 and 100s/mm2 
(102).  
Studies have attempted to optimise the b-value sequence for different tissues (104), i.e. liver 
(115,116), kidney (45,117), prostate (118), breast (119). The optimisation is relative to the 
fitting of the ADC and is focused on attaining the optimal statistical fit for the IVIM method. 
This optimisation relies heavily on the assumption that the behaviour of biological tissue is 
best explained by the IVIM model. 
In low perfused tissues such as the brain, the perfusion compartment is subtle and more b-
values are required, with even more sampling the signal at b-value<200s/mm2 (Table 2.2). 
 
Table 2.2: b-value sequences used for IVIM measurements in the brain 
Study b-value sequence (s/mm2) 
C.Federau et al.(120) 16[0, 10, 20, 40, 80, 110, 140, 170, 200, 300, 400, 500, 600, 700, 800, 900] 
E. Meeus et al.(121) 11[0, 20, 40, 80, 110, 140, 170, 200, 300, 500, 1000] 
W. C. Wu et al.(111)  12 [0, 15, 30, 45. 60, 100, 250, 400, 550, 700, 850, 1000] 
S. Zhang et al.(122) 13[0, 10, 20, 30, 50, 80, 100, 150, 200, 300, 400, 600, 800] 
Y. Yao et al.(123) 15[0, 20, 40, 80, 110, 140, 170, 200, 300, 400, 500, 600, 700, 800, 900, 1000] 
S. Bidas et al.(124) 14[0, 5, 10, 20, 30, 40, 60, 80, 90, 100, 200, 700, 1000, 1300] 
 
There is no consensus for the number of b-values required for measuring IVIM effects in the 
brain, typically more than ten b-values are implemented. Most studies assume that the 
perfusion effects are limited to the low b-values, but these may extend to 600s/mm2 in the 
brain with the limit predicted to be tissue and pathologically dependent (104). Different b-
value sequences sensitise the signal to different compartment behaviours and can greatly 
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impact the measured IVIM parameters (119). It is paramount that the b-value sequence 
implemented is optimised.  The relationship between the b-value sequence and the effect on 
the diffusion signal should be fully understood.  
2.3.3.2 Fitting Method 
The fitting method implemented will impact the estimated parameters (125). The IVIM 
method can be fitted on a pixel-wise basis with an unconstrained non-linear least-squares 
fitting algorithm- i.e. the Levenberg-Marquardt algorithm. This unconstrained fitting method 
is known to be sensitive to noise and can lead to incorrect perfusion measurements (37). 
Alternatively, the diffusion signal can be fitted using a two-step process. The perfusion effects 
are assumed to only dominate the low b-value regime.  A log-transformation is applied to the 
diffusion signal and IVIM-D calculated using a linear fitting method with b-values >200 
s/mm2. The Levenberg-Marquardt algorithm is then fitted across the whole diffusion signal to 
calculate IVIM-f and IVIM-D* (121). Another method implemented for fitting the IVIM 
equation takes the log transform of the data with b-values >200 s/mm2 and simultaneously fits 
IVIM-D and IVIM-f from the gradient and y-intercept, respectively. IVIM-D* is then 
calculated using the Levenberg-Marquardt algorithm across the whole diffusion signal. This 
fitting method has been reported to provide more accurate and reproducible IVIM parameters 
in the brain (121).  
The non-linear least-squares fitting algorithms, employed in each of these different fitting 
methods, requires initial starting values for the IVIM parameters. If the Trust Region 
Reflective algorithm is implemented, upper and lower boundaries must be specified for 
parameter fitting (126). These initial starting values can bias the parameters with the estimate 
reaching a local minimum (127). Hence, it is essential for accurate parameter estimation that 
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appropriate initial starting values are selected- these will be tissue-dependent. This is 
problematic if the tissue type is unknown- such as in cases diagnosing pathology. 
2.3.3.3 Number of Compartments 
The IVIM model assumes two compartments. In regions that are cystic or ischemic with no 
perfusion, IVIM-D* will not be defined. In such cases, IVIM-D* can be incorrectly assigned 
the same value as IVIM-D (120) and IVIM-f estimated by any value between 0 and 1, 
evidently increasing parameter variability. However, additional physical processes such as 
multiple diffusion rates within one physical component, bulk flow in tubules or glandular 
secretion (128) may also affect the detected signal (102), which would lead to more than two 
exponential components. If more than two-compartments are present, such as partial volume 
effects between brain tissue and CSF, the high diffusion coefficient of CSF can be 
misinterpreted and be incorrectly measured in the IVIM-D* parameter.  
2.3.4 Relationship of DWI models to Perfusion Measurements 
Perfusion MRI uses techniques sensitive to cerebral haemodynamics to create quantitative 
parametric maps relating to cerebral blood volume (CBV), cerebral blood flow (CBF), and 
mean transit time (MTT) (129). The three most commonly implemented techniques for 
perfusion MRI are Dynamic Susceptibility Contrast (DSC), Dynamic Contrast-Enhancing 
(DCE) imaging, and Arterial Spin Labelling (ASL) (22). 
In DSC, a Gadolinium contrast agent is injected intravenously, and a gradient-echo T2-
weighted sequence is rapidly repeated. As the bolus passes through the vascular space, it 
produces a magnetic field distortion, which depending on the concentration of Gadolinium, 
leads to a significant decrease in signal intensity (130). The signal intensity for each voxel can 
be plotted as a function of time. 
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The Gadolinium concentration is proportional to the changes observed in the rate of relaxation 
in T2. This, in turn, is proportional to the negative logarithm of the relative signal intensity. 
Hence, using a logarithm transformation, the signal intensity curve can be transformed to 
measure the gadolinium concentration as a function of time. 
Ideally, the bolus would be rapidly delivered to the tissue of interest. Unfortunately, the bolus 
is delayed and dispersed as it passes through the circulatory system. The contrast agent input 
to the tissue of interest is described by the Arterial Input Function (AIF) (131). The AIF can 
be measured from a major artery or automatically selected with software (132).  
The perfusion parameter Cerebral Blood Volume (CBV) can be estimated from the area 
below the concentration-time curve. CBV can be made a quantitative value by dividing the 
area below the concentration-time curve with the area under the AIF. The Cerebral Blood 
Flow (CBF) can be estimated with the mathematical process of deconvolving the 
concentration-time curve with the AIF. The parameter Mean Transit Time (MTT) can be 
estimated by the division of CBV with the CBF parameter. 
The DSC perfusion parameters estimated are based on several assumptions. Firstly, that blood 
flow and volume remain constant during the measurement. Secondly, the system has a linear 
response to inputs, and the output follows the principles of superpositions. Finally, the 
parameter estimations rely on the assumption that all bolus exits the system. This is an 
oversimplification as bolus can accumulate in tumours where there is a breakdown of the 
blood-brain barrier. Several strategies have been proposed to address the issue of contrast 
leakage, such as preload dosing of the contrast agent and baseline subtraction techniques to 




In the brain, DSC is the most prevalent of the perfusion measurements with demonstrable 
clinical value in the characterisation of brain tumour haemodynamics (130). DSC image 
acquisitions are short, typically 2 minutes. DCE is a similar technique, requiring a 
Gadolinium contrast agent, but instead investigates the T1 shortening effects of the bolus. 
DCE scans are typically 5-10 minutes in duration. 
There is some concern regarding the Gadolinium bolus (135). Recent studies have found 
gadolinium deposits accumulating in the brain and other organs after multiple injections of 
the contrast agent (136).  Hence a contrast free method for measuring perfusion is desirable. 
ASL doesn’t require an injectable contrast, instead relying on labelling of the arterial blood as 
it flows through the neck and into the brain (137). RF pulses are used to label protons in the 
adjacent slice with a high magnetisation such that they can be identified when they flow into 
the slice of interest, providing contrast against the stationary tissue. The use of ASL can be 
confounded by the poor signal to noise ratio of the signal acquired (34). The RF sequence 
leads to a high Specific Absorption Rate (SAR), which can cause tissue heating, restricting 
repeated use in some populations, such as children (35).  Therefore, other contrast free 
methods for measuring perfusion are under consideration with diffusion models such as IVIM 
of particular interest.  
The theorised relationships between the perfusion parameters and IVIM parameters are 






Table 2.3: Theoretical Relationship between IVIM parameters and Perfusion parameters 
IVIM Parameters Perfusion Parameters Theoretical Relationship  
𝐼𝑉𝐼𝑀 𝑓 𝐶𝐵𝑉 𝐼𝑉𝐼𝑀 𝑓 = 𝜆𝐻2𝑂
−1 ∙ 𝐶𝐵𝑉 





𝐼𝑉𝐼𝑀 𝑓 ∙ 𝐼𝑉𝐼𝑀−𝐷∗ 𝐶𝐵𝐹 




CBV- Cerebral Blood Volume; MTT- Mean Transit Time; CBF- Cerebral Blood 
Flow; λH2O- fraction of MRI visible water; L-Length of the microvascular network; 
l-mean microvessel length 
 





The parameters from the perfusion MRI techniques have been correlated with the perfusion 
related IVIM parameters with mixed success (42). H. Kim et al. found a significant positive 
correlation (0.67) between IVIM-f and CBV in the differentiation of glioblastomas (138). C. 
Federau et al. found a strong correlation (r=0.75) between DSC-CBV and IVIM-f for ROIs 
across a range of lesions (120). A correlation was also established between IVIM-f×IVIM-D* 
and DSC-CBF (r=0.65) but a weak relationship between IVIM-D* and DSC-MTT (r=-0.27) 
was attained. Other studies have also struggled to validate the theorised relationship between 
IVIM-D* and mean transit time (MTT) (139). S. Bisdas et al. found no clear link between the 
perfusion related IVIM parameters and the DSC- and DCE- derived metrics in gliomas (140). 
This poor relationship could be due to the different theoretical background and modelling of 
the tumour vasculature in the IVIM theory (140), or due to the fitting method implemented for 
estimating IVIM-f and IVIM-D* (141). The correlation between the perfusion parameters and 
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the diffusion signal require further investigation to determine the feasibility of DWI 
parameters being used as a surrogate for perfusion measurements. 
2.3.5 Multicompartment Modelling 
One of the setbacks of the IVIM model is the assumption of two compartments. This has led to 
investigations into three-compartment models and the fitting of tri-exponential equations: 
𝑆(𝑏)
𝑆(0)
= 𝐴𝑒−𝑏𝛼 + 𝐵𝑒−𝑏𝛽 + 𝐶𝑒−𝑐𝛾 (2.14) 
Studies have shown that at high b-values, diffusion can be differentiated into fast (free 
diffusion) and slow (restricted diffusion) compartments (142,143). Triexponential studies have 
been performed in liver cirrhosis (144), prostate cancer (145),  the characterisation of brain 
tissue (146)(147), and glioma grading (148). In each case, a triexponential fit was found to be 
the optimum statistical fit in comparison to the bi-exponential or mono-exponential fit. This 
suggests that more detailed tissue diffusion can be attained with the additional parameters.  
Similar challenges that confound IVIM are further exacerbated by the tri-exponential fitting 
method. Different b-value sequences and fitting methods are implemented in each of these 
studies. The simultaneous fitting of additional coefficients may result in parameter overfitting 
(149). At high b-values, the assumption of molecular diffusion following a Gaussian 
distribution breaks down. For b-values > 1000s/mm2, deviation from Gaussian behaviour is 
quantified by kurtosis, a dimensionless statistical metric (150). None of the tri-exponential 
models mentioned considering fast and slow diffusion account for kurtosis, despite sampling 
high b-values. The biophysical basis for the two diffusion compartments has been linked to 
extra- and intracellular compartments (147). This is contested by several studies where bi-
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exponential behaviour was observed to govern diffusion within a single cellular compartment 
(151)(152). The physiological basis for two diffusion compartments is not yet fully understood. 
Tri-exponential diffusion signals with two perfusion and one diffusion compartment have also 
been considered with success in differentiating kidney lesions (153) and monitoring kidney 
function (154) and characterising liver tissue (155)(156). Two-compartment perfusion models 
have largely focused on high perfused tissues, where the rationale for fast and slow perfusion 
comes from two different flow regimes (154) from capillaries and medium-sized vessels. 
However, the fast perfusion compartment decays rapidly and can be difficult to measure (35), 
requiring a very short TR. 
2.3.6 Other Diffusion Models 
Other equations have been suggested for modelling the diffusion signal. Within one voxel there 
are a multitude of cells and different components, each with different spin packets, and different 
diffusivities, contributing to the overall detected signal. The stretched exponential model (SEM) 
(157) argues that the number of contributing components cannot be known and should instead 






Where DDC is the distributed diffusion coefficient, the mean diffusivity for the voxel, and α is 
the heterogeneity index, a dimensionless parameter ranging from 0 to 1. If only one 
compartment contributes to the signal, α would be 1, and the SEM model would be 
mathematically equivalent to the ADC model. The lower the value of α, the greater the 
heterogeneity. However, the physiological basis for α is uncertain, and therefore α is not yet 
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considered a true biomarker (102). The SEM also doesn’t take perfusion effects into 
consideration. 
The Diffusion Kurtosis Model (DKI) (158) accounts for non-Gaussian behaviour at high b-




2𝐷2𝐾 6⁄ (2.16) 
Where D is the apparent diffusion coefficient, and K is the apparent diffusional kurtosis. The 
DKI model doesn’t take perfusion effects into consideration; however, DKI has been 
incorporated into a hybrid DKI-IVIM model (159)(160). DKI is sensitive to noise due to the 
strong diffusion weightings at high b-values and modelling of the signal with low SNR can be 
challenging (161). In this project, only b-values ≤1000s/mm2 were measured, and the DKI 
model was not considered any further.  
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2.4 Multi-exponential fitting methods 
Fitting of multi-exponential equations to experimental data is a notable problem for many 
different scientific fields. The number of exponential terms within a signal, the decay 
coefficients of each term along with the fractional value of each term, indicating each 
component’s contribution to the overall signal, all have to be determined (162). The accuracy 
of such models is of particular importance in the biomedical field, where multi-exponential 
decay is common and robust biomarkers are required. The complex fitting problem is further 
exacerbated by the poor signal to noise ratios (SNRs) and a limited number of data points (163). 
Diffusion studies considering a range of multi-exponential models will typically use iterative, 
non-linear least-squares fitting techniques such as the Levenberg-Marquardt or the Trust-
Region Reflective algorithm (127) to fit each of the models considered. The optimum model 
will then be decided by which equation provided the best statistical fit. However, a whole range 
of different methods exist for determining the number of exponential components present in a 
signal. Most of these have been developed to describe time series data and we use that language 
in this section. 
2.4.1 Graphical Methods 
Graphical methods attempt to determine the number of exponential components through 
visual inspection. A logarithm is performed and a straight line drawn through the data. The 
cut-off point at which the data begins to deviate from the straight line determines the location 
of the second compartment. Data contributing to the first compartment is removed and the 
process repeated until all compartments are identified. This problem was initially solved by 
hand (164), but advances in software eventually lead to the development of computational 
tools (165). Although simple to execute, graphical methods are subjective and prone to high 
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errors (166). The results are not very accurate, depending on the user-defined cut-off values 
and the method fails when more than two components are present (167). 
2.4.2 Iterative Methods 
Iterative methods start with a user-defined initial guess. The algorithm then iterates, 
improving the approximate solution at each step. The algorithm stops once a user-defined 
level of convergence or the maximum number of iterations is attained. Iterative methods 
require good initial starting guesses to ensure that convergence reaches a global minimum- 
this does require some prior knowledge about the system. If a good initial starting value is not 
provided, the algorithm has to go through many iterations making the method 
computationally expensive. Noisy data can exacerbate the time taken for the algorithm to 
convergence and can result in convergence at a local minimum.  
2.4.3 Algebraic Methods 
Exponential models can be fitted to data using algebraic methods, where simultaneous linear 
equations are solved. A popular method for solving exponential summations is the Prony 
method (168). The signal is regarded as a solution of a homogeneous linear difference 
equation (LDE) with constant coefficients (169). The solution to the LDE will be a 
summation of complex exponentials. Therefore, by solving the LDE, the coefficients of the 
exponential summation can be attained.  The Prony method is restricted to data equally spaced 
in time (163). Also, the Prony algorithms have been demonstrated to be highly susceptible to 
noise and perform poorly when trying to determine the number of exponential terms in signals 
with a large number of components (162,163). Many modifications to the Prony method have 




2.4.4 Transform Methods 
Transform methods have also been developed (162), in which the data is Fourier transformed 
to create a spectral plot with spikes representing exponential components (163). A popular 
technique, known as the Gardner method, uses a Laplace transformation- a continuous integral.  
However, this approach exacerbates high-frequency noise in the deconvolution process (172), 
causing ripples and broadening of the spectral peaks, making interpretations of the results 
difficult.  
2.4.5 Model Selection 
Selecting the optimum number of exponential terms to model a data series is a challenging 
task. Complex models can minimise the error but result in overfitting the data. To avoid the 
risk of overfitting, the Akaike Information Criterion (AIC) (173), is commonly implemented 
as a means of model selection. The AIC estimates the relative quality of each of the 
multiparametric fitting methods, rewarding for goodness of fit and penalising for the 
complexing (Equations 2.15) 
𝐴𝐼𝐶 = 𝑛 ∙ ln (
𝑅𝑆𝑆
𝑛
) + 2𝑘 (2.17) 
Where RSS is the residual sum of squares, n is the number of data points in the sequel, and k 
is the number of parameters in the model. The model with the lowest AIC value is considered 




2.5 The Auto-Regressive Moving Average Model 
2.5.1 The ARMA model 
The Auto-Regressive Moving Average (ARMA) model has been evaluated for the fitting of 
multi-exponential data (174). ARMA models were considered due to their ability to fit a 
broad range of data types without making any previous assumptions about the data. The 
ARMA model is established through a series of equations which can be classified into two 
subsets- the Auto-Regressive (AR) part and the Moving Average (MA) part. The AR model is 
a time series in which the current value of a system is dependent upon a linear function of 
previous values. AR(P), an AR model of order P is described by:  




Where the order P specifies how many lagged terms there are, y(t) is the signal at time point t, 
y(t-j) are the lagged signal values at point t-j with lag j, and αj are the multiplication 
coefficients. 
The MA model in a time series has terms dependent upon past errors, or input values. MA 
(Q), a MA model of order Q and dependent upon Q lagged terms, is specified by: 





 where x(t − 𝑖) are the lagged input values at time (t − 𝑖) with lag 𝑖, and 𝛽𝑖 are the 
multiplication coefficients. Hence an ARMA model is a linear combination of these two 











𝑗=1⏟        
𝐴𝑢𝑡𝑜 − 𝑅𝑒𝑔𝑟𝑒𝑠𝑠𝑖𝑣𝑒
(2.20) 
The 𝛼𝑗 and 𝛽𝑖 coefficients are determined such that the error between the data and the model 
are minimised. Upon selecting the order of the ARMA model, the coefficients are determined 
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Y is a matrix engineered from the previous input and output terms. A is the matrix of ARMA 
coefficients, and Ypred is the final model of the predicted signal. By solving the normal 
equation such that:  
𝑌 ∙ 𝐴 = 𝑌𝑃𝑟𝑒𝑑 (2.22) 
the ARMA coefficients are minimised and the model Ypred established.  
2.5.2 Interpretation of the ARMA model 
The ARMA model is a popular forecasting tool used to study economics and financial time 
series (176)(177). In these applications, the crucial focus is to implement the ARMA model to 
enable the prediction of future time points- the interpretation behind the optimum ARMA 
order or corresponding coefficients is not of interest  
In general, the ARMA models are considered atheoretical (178). However, it is theorised that 
more complex data will require modelling with a higher-order ARMA model (179).  For 
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exponential fitting, it is postulated that the optimum ARMA order will be dependent on the 
number of exponential components present in the signal. A MA(1) process can be modelled as 
an infinite AR process, AR(∞) (180).To ensure each component is fully independent of one 
another, only ARMA(P,Q) orders with P≥Q will be considered.  To avoid overfitting, the 
maximum order considered is limited to ARMA(3,3) with up to 99% of datasets modelled by 
no more than a third-order lag term (181). 
The interpretation of the minimisation coefficients is challenging. For AR(1) models, the 
lower the value of α1, the quicker the rate of convergence. AR(1) structure imposes an 
exponential decay rate (182) and α1 inversely correlates with the decay rate. For MA(1) 
models, the convergence to the mean is linear (183). Higher-order ARMA models can model 
increasingly complex behaviour. For the application of ARMA to exponential decays, the 
signal is not stochastic and will follow trends similar to that of AR(1). The α and β ARMA 
minimisation coefficients will, therefore, relate to the magnitude of decay. The modelling of 
the diffusion signal with the ARMA model will be explored in the next chapter. 
2.5.3 Applications of the ARMA model to MR 
The ARMA model has been implemented for time series analysis across a range of MR data. 
ARMA models have been used to model the error caused in the reconstruction of MR images 
after a Fast Fourier Transform (184). ARMA models have been implemented for the 
calculations of T2 and chemical shift in cases with a limited number of sparsely sampled 
echoes (185)(186). ARMA models have also effectively fitted contrast perfusion signals in 
cardiac MRI (187)(188)(189). 
In each of these studies, ARMA was applied to MR time series data and used as an 
atheoretical model. In the subsequent chapters, the ARMA model is modified for the 
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interpretation of the diffusion signal. The optimum ARMA order and the corresponding α and 
β coefficients are investigated and related to multi-component behaviour, as well as tissue 











3. The ADAPT Method for Model Selection 
In this chapter, the ARMA model is introduced as the ADAPT model, modified for DWI 
signals. A full mathematical formalism is provided and discussed. The methodology for using 
ADAPT to determine the number of components in the diffusion signal is presented. A partial 
volume effects model, combining white matter and cerebrospinal fluid signals is investigated 
and the results compared to those of multi-exponential fitting methods. Once optimised, 
ADAPT is fitted to In-Vivo data. 
3.1 Introduction 
Multi-exponential fitting is a challenging task for diffusion-weighted magnetic resonance 
imaging (DW-MRI) data, where there are a limited number of data points, and the number of 
components within the diffusion signal is unknown. Theoretical and experimental studies have 
suggested that water diffusion in biological tissue is characterised by multi-exponential 
behaviour (35,145,147). Diffusion-weighted imaging (DWI) has been demonstrated to have 
clinical relevance for identifying areas of cerebral ischemia and oncological diagnosis (190). 
As the reported diffusion coefficient is dependent upon the fitting method implemented, it is 
crucial that the optimum method is realised. 
In order to attain the diffusion coefficient for each voxel in the MR image, the scan is repeated 
at different b-values (84). The b-value is related to the duration, strength and time-spacing of 
these two gradient pulses. As the b-values increase, so does the sensitivity to particle motion, 
and the detected signal attenuates exponentially. By plotting the signal on a logarithmic scale 
and calculating the gradient, the diffusion coefficient for that voxel is attained (91) — the 
greater the signal attenuation, the greater the rate of diffusion. 
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Multi-component models have been applied to DWI data previously, and the most common is 
the Intravoxel Incoherent Motion (IVIM) method (90). The IVIM method assumes that the 
signal is composed of two exponentials, accounting for tissue water diffusion and bulk flow in 
small blood vessels. When plotted on a logarithmic scale, the gradient of each component 
provides the diffusion related coefficients for each exponential term. If IVIM is fitted using the 
Levenberg-Marquardt algorithm, initial starting values for the parameters are required, and the 
fitting stability is often improved by using a multistep fitting approach (191). However, the 
assumption that only two components exist might not be appropriate in some cases. Additional 
physical processes (192) and cases where a voxel contains partial volumes (i.e. a mixture of 
brain tissue and fluid) may lead to more than two exponential components. Hence, a method 
that can optimise the number of components could provide new insight into the physical 
properties of water motion in tissue. 
Several variables have to be defined for multi-exponential fitting. The number of exponential 
terms, the magnitude and the fractional contributions to the signal all have to be determined 
(162). Common exponential fitting methods such as graphical methods are simple to execute 
but are subjective and prone to high errors (166). Parametric techniques, such as the Prony 
method which provide a solution as a series of damped sinusoids (168), are also commonly 
implemented but are highly sensitive to noise. Transform methods have also been developed 
(162), in which the data is Fourier transformed to create a spectral plot with spikes representing 
exponential components (163). However, this approach exacerbates high-frequency noise in the 
deconvolution process (172), and interpretations of the results can be difficult. Overall, there is 
a need to develop improved analysis methods for multi-exponential data. 
Auto-Regressive Moving Average (ARMA) models (174) are generalised versions of multi-
exponential models and can predict the behaviour of a data series from previous values alone. 
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ARMA has the flexibility to represent a wide range of data series, with the order (number of 
lag terms) of the optimum ARMA model relating to the complexity of the data. However, such 
a method is restricted to the time domain. Therefore, this chapter aimed to develop a new 
generalised fitting method for multi-exponential data where the number of components is 
unknown a priori and evaluate it on simulated and real multi b-value DWI data.   
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3.2 Materials and Methods 
3.2.1 The Auto-regressive Discrete Acquisition Points Transformation 
(ADAPT) Method 
To adapt the ARMA equation for the modelling of DWI data, the method was modified 
henceforth referred to as the Auto-regressive Discrete Acquisition Points Transformation 
(ADAPT) method. ADAPT models the diffusion signal by the equation:  






Where Sn-Signal at acquisition point n; bn- b-value at acquisition time point n. αj, βi- 
minimisation coefficients. Here the acquisition point of the b-values is used such that b value=0 
s/mm2 at acquisition point 0, b(0)=0. b-value=20 s/mm2 at acquisition point 1, b(1)=20 and so 
forth. The previously acquired b-values are therefore used as previous input terms. Upon 
selecting the order of the ADAPT(P,Q) model, the α and β minimisation coefficients are 
determined such that the error between the data and the model is minimised. The coefficients 
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S is a matrix engineered from the input b-values and the detected signal with acquisition point 
n=0, …, N. A is the matrix of ADAPT coefficients. Spred is the final model of the predicted 
signal normalised by S(0)- the initial signal value at b=0 and n=0. By solving the normal 
equation such that:  
S ∙ A = Spred (3.3) 
the ADAPT coefficients are minimised and the model Spred is established.  
 
3.2.1.1 Determining the Number of Components 





β0 + β1L̂ + ⋯+ βPL̂
P
1 − α1L̂ − ⋯− αQL̂Q
 (3.4) 
Where L̂ is the lag operator (181) such that  ln(Sn) L̂ = ln(Sn−1). By mapping the transfer 







1 − α1z−1 −⋯− αQz−Q
 (3.5) 
Equation 3.5 can be rearranged using partial fraction decomposition. An inverse Z-transform 
was then performed, and the number of components established.  
3.2.1.2 ADAPT(1,1) 
For example, ADAPT(1,1) gives: 
ln(Sn) = β0bn + β1bn−1 + α1 ln(Sn−1) (3.6) 























− β0 (3.9) 
 









ln(Sn) = β0bn + α1 ln(Sn−1) (3.11) 
  





Performing partial fraction decomposition (PFD) and an inverse Z transform:  
H(n) = β0α1
n (3.13) 
Hence ADAPT(1,0) was also evaluated to be a one-component decay model.  
3.2.1.4 ADAPT(2,0) 
ADAPT(2,0) gives: 
ln(Sn) = β0bn + α1 ln(Sn−1) + α2 ln(Sn−2) (3.14) 








(z − r1)(z − r2)
 (3.15) 
Where the denominator is factorised such that r1 and r2 are roots of the quadratic expression. 




Where A and B represent the numerators that would be attained through the PFD. Hence 
ADAPT(2,0) was also evaluated to be a two-component decay model.  
3.2.1.5 ADAPT(2,1) 
ADAPT(2,1) gives: 
ln(Sn) = β0bn + β1bn−1 + α1 ln(Sn−1) + α2 ln(𝑆𝑛−2) (3.17) 






z2 − α1 − α2
 (3.18) 




Where r1 and r2 are roots of the quadratic expression in the denominator of the transfer function 
and C and D, represent the numerators that would be attained through the PFD. Hence 
ADAPT(2,1) was also evaluated to be a two-component decay model.  
3.2.1.6 ADAPT(3,1) 
ADAPT(3,1) gives:  
Ln(Sn) = β0bn + β1bn−1 + α1 ln(Sn−1) + α2 ln(Sn−2) + α3 ln(Sn−3) (3.20) 








(z − r1)(z − r2)(z − r3)
 (3.21) 
Where the denominator is factorised such that r1, r2 and r3 are roots of the cubic expression. 





Where F, G and H represent the numerators that would be attained through the PFD. Hence 
ADAPT(3,1) was evaluated to be a three-component decay model. 
3.2.2 Data Simulations 
All simulated and acquired In-Vivo data was created or obtained using a range of 11 
exponentially spaced b-values between 0 and 1000 [0, 20, 40, 80, 110, 140, 170, 200, 300, 500, 
1000] s/mm2. All simulations and data analysis were conducted using MATLAB (MathWorks, 
Natick, MA, USA, v.2016b).  
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3.2.2.1 Simulation of a Bi-exponential Signal 
A range of bi-exponential diffusion signals were created by simulating data using the equation 
for the IVIM method: 
S(b)
S(0)
= f ∙ exp−bD
∗
+ (1 − f) ∙ exp−bD (3.23) 
 Where S(b)/S(0) is the signal intensity for a particular b-value, b, normalized by the signal 
intensity when b=0 s/mm2; D is the tissue diffusion coefficient; D* is the pseudo-diffusion 
coefficient (related to the perfusion of blood in the capillary network); and f is the volume 
fraction of incoherently flowing blood in the tissue describing the fraction of the signal arising 
from the vascular network (91). 
Bi-exponential signals were created with a range of f values (0.1, 0.3 and 0.5) and three different 
D*/D ratios corresponding to those observed in the brain, kidney and liver (10, 20 and 70 
respectively) (45). The D parameter was fixed at 0.0007 mm2/s and the D* parameters 
considered were 0.007 mm2/s, 0.014 mm2/s and 0.049 mm2/s. Random white Gaussian noise 
was added to the simulated signals to mimic SNR levels of 50, typical of those measured In-
Vivo data. The ADAPT method was applied to the bi-exponential signals, and a range of orders 
from ADAPT(0,0) to ADAPT(3,3) were considered.  
3.2.2.2 Simulation of a Multi-Component Partial Volume Effects Model 
A partial volume effects (PVE) model was simulated, in which compartments from both 
cerebral white matter (WM), assumed to be a two-compartment model, and cerebrospinal fluid 






= Ae−bα + Be−bβ + Ce−bγ (3.24) 
Such a tissue model is of particular interest to DWI, as the use of the IVIM method in the brain 
requires cautious interpretation in regions of tissue edges due to PVE. The high value of the 
diffusion coefficient in CSF and the much lower diffusion coefficient in WM results in the 
incorrect detection of a large perfusion value within the cerebral cortex, when a voxel contains 
information from both these regions (42). CSF was assumed to exhibit mono-exponential 
behaviour with a diffusion coefficient assumed to be that of free water at  37℃  ( DCSF =
3 × 10−3mm2/s) (80). WM was assumed to be represented by the bi-exponential IVIM 
method. The WM model parameters were taken from averaged IVIM values previously 
reported in a volunteer study (fWM = 0.07; DWM = 0.77 × 10
−3mm2/s ; D∗WM = 7.9 ×
10−3mm2/s )(111). A partial volume effect (PVE) model was created as a summation of the 





−bDCSF + (1 − fCSF)(fWMe
−bD∗WM + (1 − fWM)e
−bDWM) (3.25) 
Where fCSF indicated the fraction of the signal that was contributed by the CSF compartment. 
A range of PVE models were created with varying CSF:WM ratios (100:0, 75:25, 50:50, 25:75 
and 0:100). White Gaussian noise was added to PVE models to mimic SNR levels ≈ 50. 
3.2.2.3 Robustness Analysis 
Poor signal quality can result in a change of parameter values or in the detection of an additional 
component. Hence the effects of poor SNR on the robustness of the fitting methods were 
investigated. Random white Gaussian noise was added to the simulated signals to mimic SNR 
levels between 20 and 100. Although the noise present in MRI data is governed by a Rician 
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noise distribution, the distribution is approximately Gaussian for the SNR levels considered in 
this study (121). Noise was added using the MATLAB Communications System Toolbox ‘Add 
White Gaussian Noise’ (awgn) function. The data simulations were performed using 1000 
random data iterations for each model and SNR level. 
3.2.3 Physical Phantom 
A physical phantom with multiple compartments containing varying Deuterium Oxide (D2O)/ 
H2O mixtures was designed and scanned to further consider the effects of partial volumes. 
The phantom was created with two hydrogel compartments: the bottom layer, Agarose gel 
formed with 10% D2O/90% H2O; the top layer, Agarose gel formed with 100% H2O and N-
Acetylaspartic acid (NAA). A balloon filled with water was suspended between the two 
hydrogels. The phantom was scanned with the same diffusion protocol used for In-Vivo data 
acquisitions (3.2.4). 
3.2.4 In-Vivo Data Acquisition 
A volunteer brain scan (age 25 years), SNR≈50 in WM at b-value = 0 s/mm2, was acquired on 
a Philips Achieva 3T TX (Philips Healthcare, Best, the Netherlands) MRI scanner at 
Birmingham Children’s Hospital using a 32-multichannel receiver head coil. A patient (age 3.2 
years) with a brain tumour, suprasellar pilomyxoid astrocytoma, was also scanned. The patient 
case was considered as the ventricles were enlarged due to hydrocephalus, allowing for an 
easier investigation of the one compartment CSF. It should be noted that no tumour was present 
on the slice considered. Informed parental consent was obtained for all subjects and the 
East Midlands – Derby Research Ethics Committee (REC 04/MRE04/41) approved the study 
operating under the rules of Declaration of Helsinki 1975 (and as revised in 1983). The 
diffusion-weighted MRI sequence used a sensitivity-encoded (SENSE) approach with the 
67 
 
following parameters: b-value data acquired in three orthogonal directions, FOV 230mm x 
230mm, TR/TE 3,214/84ms, matrix size 256x256, 5mm slice thickness and in-plane resolution 
0.9mm x 0.9mm. The spectral presaturation with inversion recovery (SPIR) was used for fat 
suppression and the scan duration was 2.21 minutes. 
3.2.5 Data Analysis 
3.2.5.1 Measuring SNR 
In-Vivo SNR levels were calculated using the standard NEMA method based on the difference 
image from two acquisitions; this is the recommended method for determining SNR when 
parallel imaging techniques are used (77). The quality of parameter estimation depends strongly 
on the SNR, with the SNR for the low IVIM perfusion regime recommended to be above a 
critical value of 40 (45,121). An SNR≈50 was recorded in the White Matter (b-value =0), in 
agreement with previous studies using this acquisition protocol (191). 
3.2.5.2 Model Selection 
The Akaike information criterion (AIC) (173) was used as a means of model selection for 
determining the optimum ADAPT order. The AIC estimates the relative likelihood of a model 
being the optimum fit by measuring the trade-off between goodness of fit and model 
complexity. Such a selection process aims to reduce the risk of over-fitting. As the b-value 
sequence used within the diffusion-weighted imaging (DWI) protocol typically has less than 30 
b-values (11 in the cases considered), they can be considered to be a finite data set (35). Thus 
the corrected AIC (AICc) (193), with a harsher penalty for overfitting, was implemented. The 
AICc formula (11): 









Where n is the number of b-values used to fit the signal; k is the number of parameters; and 
RSS is the residual sum squared.  The fit with the lowest AICc value is considered to be the 
optimum fit. The number of parameters, k, includes the diffusion signal S0 (194) and an 
additional parameter is counted due to the Gaussian noise hypothesis for the signal residuals 
(35).There is a debate in the literature that the AIC is only suitable for analysing nested models 
and is consequently inherently biased. Although the models in this study are nested, other 
studies have shown the AIC as a suitable criterion for a wide range of model types, both nested 
and non-nested (195). However, to ensure that such a selection criterion is not ad-hoc, an 
additional selection criterion is also considered- the Bayesian Information Criterion corrected 
for small samples (BICc) (196).  
It is advocated that an approach of using two criteria together can increase the confidence in 




+ n ∙ log (
RSS
n
) (3.27)  
The relative significance of the optimum information criterion fit was justified with the use of 
Bayes Factors (198) where wi is the Weight, indicating the probability of model i being the 
optimum model and the associated statistic the log evidence ratio (LER)  indicates evidence for 












Where M is the number of compared models and:  
∆iAICc = AICc(i) − AICcmin (3.29)
Where AICcmin is the minimum AICc value of all the models considered. The Akaike weight 







Where wmax is the Akaike weight of the optimum model. The LER is provided by taking the 
log of the ER such that. 
LERi = log10(ERi) (3.31) 
LER values greater than 0, 0.5, 1 or 2 indicate respectively that the evidence is ‘minimal’, 
‘substantial’, ‘strong’ or ‘decisive’. 
 
3.2.5.3 Statistical Analysis 
For the data simulations, correlation analysis (Pearson correlation coefficient, r) was performed 
to determine how the ADAPT(1,1) coefficients were related to the IVIM parameters. 
ADAPT(1,1) was considered as it was found to be the optimum fit for bi-exponential equations. 
The IVIM parameters were calculated using the multi-exponential fitting methods as described 
in the section below (Section 3.2.5.4). The statistical significance of the relationship was 
assessed using the p-value (P <0.05). The robustness of the ADAPT and multi-exponential 
coefficients, when fitted to the PVE models, was assessed by calculating the coefficient of 
variation (CV) over the 1000 iterations measured. 
For the In-Vivo data, correlation analysis (Spearman’s rank correlation coefficient, s) was 
performed to compare the ADAPT(1,1) coefficients to the IVIM parameters. ρ values between 
0.60 - 0.79, and 0.80 - 1.0 were considered to represent a ‘strong’ and ‘very strong’ correlation 
respectively. Five regions of interest (ROIs), each 4x4 pixels, were selected from within both 
the one compartment CSF and the two-compartment WM. The ROIs were drawn upon the DWI 
scans with no additional filtering. The optimum ADAPT and multi-exponential fitting methods 
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were fitted to each of the ROIs. To investigate the robustness of the fitting parameters, the 
average parameter value and CV was calculated.  
3.2.5.4 Multi-exponential Fitting Methods 
The bi-exponential fitting method for the IVIM equation was assessed using non-linear least-
squares minimisation, with the Levenberg-Marquardt algorithm and a constrained 2-parameter 
fitting method (121). The tri-exponential fitting method used the same minimisation technique 
and a constrained 4-parameter fitting method. The mono-exponential fitting method was also 
considered for the PVE models and In-Vivo data. By plotting the signal on a logarithmic scale 
and calculating the gradient, the Apparent Diffusion Coefficient (ADC) is attained. 
3.2.5.5 Performance of Fitting Methods 
All calculations were performed on OS: Windows 10 Pro 64-bit (10.0 Build 16299), CPU: 
AMD Ryzen 5 1600, 3.2 GHz, Memory: 8192 MB DDR4 RAM.  To compare the performance 
of the ADAPT and IVIM fitting methods, the CPU run time of each method was recorded and 





3.3.1 ADAPT Method Applied to Simulated Bi-exponential Signal 
3.3.1.1 Selection of Optimum Fit 
 A range of ADAPT orders were fitted to the simulated bi-exponential signal (SNR ≈ 50) with 
varying IVIM parameters (Figure 3.1).  
 




For each of the 9 scenarios considered ADAPT(1,1) was found to be the optimum order, having 
the lowest AICc for every case (Table 3.1).  
 
For the bi-exponential signals where D*/D=10, the competing order ADAPT(2,1) was found to 
have an AICc-LER just below 0.5 in two instances. For the bi-exponential signals with 
D*/D=70 and f=0.3 or 0.5, the AICc-LER ratio indicates that ADAPT(1,0) and ADAPT(2,0) 
are competing orders that should also be taken into consideration. ADAPT orders (2,2), (3,0), 
(3,1), (3,2) and (3,3) were also considered for each case but possessed comparatively higher 
 
Table 3.1: ADAPT Orders Fitted to Bi-exponential Diffusion Signals-AICc 
   ADAPT Orders 




AICc -73 -97 -120 -97 -115 
𝐿𝐸𝑅𝐴𝐼𝐶𝑐  10.0
6 4.85 0 4.94 0.92 
0.3 
AICc -49 -79 -101 -80 -98 
𝐿𝐸𝑅𝐴𝐼𝐶𝑐  11.2
2 4.74 0 4.39 0.49 
0.5 
AICc -36 -68 -91 -69 -89 
𝐿𝐸𝑅𝐴𝐼𝐶𝑐  11.8
7 5.03 0 4.75 0.42 
20 
0.1 
AICc -65 -88 -106 -93 -103 
𝐿𝐸𝑅𝐴𝐼𝐶𝑐  8.93 3.88 0 2.98 0.67 
0.3 
AICc -39 -68 -82 -73 -79 
𝐿𝐸𝑅𝐴𝐼𝐶𝑐  9.35 3.12 0 2.02 0.70 
0.5 
AICc -25 -56 -71 -61 -68 
𝐿𝐸𝑅𝐴𝐼𝐶𝑐  9.90 3.21 0 2.07 0.70 
70 
0.1 
AICc -59 -78 -84 -80 -80 
𝐿𝐸𝑅𝐴𝐼𝐶𝑐  5.39 1.24 0 0.75 0.70 
0.3 
AICc -32 -56 -58 -57 -55 
𝐿𝐸𝑅𝐴𝐼𝐶𝑐  5.58 0.48 0 0.23 0.66 
0.5 
AICc -18 -43 -45 -44 -42 
𝐿𝐸𝑅𝐴𝐼𝐶𝑐  5.84 0.39 0 0.09 0.62 
A range of two compartment bi-exponential diffusion signals (SNR≈50) were investigated with a 
range of IVIM-D*/D ratios and IVIM-f values. The ADAPT method was applied to the bi-exponential 
signals and the optimum fit (highlighted) was selected by choosing the method with the lowest AICc. 














AICc values and thus very high AICc-LERs. The BICc confirmed that the optimum order was 
ADAPT(1,1) (Table 3.2). No competing orders were detected when D*/D=10. For the signals 
with D*/D=70 and f=0.3 or 0.5, the BICc indicated that ADAPT(1,0) was the optimum order. 
However, the BICc-LER for ADAPT(1,1) was low and the BICc values almost equivalent. 
 
3.3.1.2 Number of Components 
The Transfer function, Z-transform, PFD and subsequent inverse Z-transform were performed 
on ADAPT(0,0), ADAPT(1,0), ADAPT(1,1), ADAPT(2,0) and ADAPT(2,1). ADAPT(0,0) is 
equivalent to the mono-exponential model and thus, a one-component decay model. As 
 
Table 3.2: ADAPT Orders Fitted to Bi-exponential Diffusion Signals-BICc 
   ADAPT Orders 




BICc -68 -89 -109 -86 -101 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 8.79 4.19 0 4.94 1.67 
0.3 
BICc -46 -74 -93 -72 -87 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 10.0
4 4.13 0 4.39 1.15 
0.5 
BICc -34 -63 -83 -61 -78 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 10.7
0 4.42 0 4.75 1.08 
20 
0.1 
BICc -63 -83 -99 -85 -92 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 7.76 3.28 0 2.98 1.33 
0.3 
BICc -37 -63 -74 -65 -68 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 8.18 2.51 0 2.02 1.36 
0.5 
BICc -23 -51 -63 -53 -57 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 8.72 2.61 0 2.07 1.36 
70 
0.1 
BICc -56 -73 -76 -72 -69 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 5.39 1.24 0 0.75 0.70 
0.3 
BICc -30 -50 -50 -49 -44 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 4.53 0 0.12 0.35 1.44 
0.5 
BICc -15 -38 -37 -36 -42 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 4.88 0 0.21 0.30 0.62 
The optimum ADAPT order for the simulated bi-exponential diffusion signals was selected using the 





previously stated, ADAPT(1,1) was evaluated to be a two-component decay model. In all bi-
exponential simulations considered, a two-component model was found to be the optimum fit, 
based upon the AICc. ADAPT(2,0) and ADAPT(2,1), which were found to be competing 
orders are also two-component decay models. ADAPT(1,0), a one-component decay model, 
was found to be a competing order for some cases. However, for the D*/D ratio of 70 and f 
value of 0.3, the AICc-LER of ADAPT(1,0) is 0.48 is close to the cutoff and the wi 
probability (ADAPT(1,0) wi=0.14) is more than half that of the optimum order (ADAPT(1,1) 
wi=0.43). ). Using the BICc,  ADAPT(1,0) was identified as the optimum order (wi=0.44). 
However, the BICc-LER for ADAPT(1,1) was very low, 0.12 and wi= 0.33.  For the D*/D 
ratio of 70 and f-value of 0.5, the wi probability of ADAPT(1,0)  (ADAPT(1,0) wi=0.15) is 
more than half that of the optimum order (ADAPT(1,1) wi=0.37). ADAPT(1,0) had the lowest 
BICc and was selected as the optimum order (wi=0.46); however, the BICc-LER for 
ADAPT(1,1) was low, 0.21 and wi= 0.28, indicating a competing model with a comparable 
probability. 
3.3.2 Tri-exponential Partial Volume Effect Models 
3.3.2.1 Selection of Optimum Order 
Mono-, bi- and tri- exponential fitting methods (Figure 3.2) were applied to the PVE models 
(SNR ≈ 50) with varying CSF:WM ratios and the optimum fit selected using the AICc (Table 











Table 3.3: Partial Volume Effects Model fitted with ADAPT orders and Multi-exponential fitting 
methods-AICc. 




 ADC IVIM TRI (0,0) (1,0) (1,1) (2,0) (3,0) (3,1) 
100:0 1 
AICc -154 -155 -154 -154 -160 -161 -159 -161 -158 
𝐿𝐸𝑅𝐴𝐼𝐶𝑐 0.32 0 0.33 1.45 0.17 0 0.32 0.02 0.55 
75:25 
3 AICc -67 -110 -154 -59 -79 -97 -78 -77 -108 
 𝐿𝐸𝑅𝐴𝐼𝐶𝑐 18.85 9.40 0 10.65 6.13 2.32 6.48 6.75 0 
50:50 
3 AICc -64 -108 -152 -60 -83 -101 -82 -80 -110 
 𝐿𝐸𝑅𝐴𝐼𝐶𝑐 18.97 9.42 0 11.01 5.83 2.02 6.08 6.59 0 
25:75 
3 AICc -68 -116 -150 -67 -92 -111 -91 -88 -116 
 𝐿𝐸𝑅𝐴𝐼𝐶𝑐 17.77 7.47 0 10.75 5.29 1.13 5.40 6.08 0 
0:100 
2 AICc -80 -140 -151 -81 -103 -128 -104 -102 -123 





A range of PVE models, with varying CSF:WM ratios, were investigated. Multi-
exponential fitting methods and the ADAPT method were fitted. The optimum fit was 
selected by choosing the method with the lowest AICc. 
 
Figure 3.2: The optimum ADAPT order and the multi-exponential models are shown fitted to the PVE 












Based on the AICc, the number of detected components did not correspond to the number of 
exponential terms presented in the signal. In particular, a tri-exponential fit was found to best 
represent both two and three-component models. The one-compartment model was best 
represented by a bi-exponential fit. However, the LER-AICc values indicated that all other 
multi-exponential fits were competing. Based on the BICc, the one compartment and three-
compartment models were correctly identified, but a two-compartment model was overfitted 
and found to be best represented by a tri-exponential fit. No other multi-exponential fits were 
found to compete. According to the AICc and BICc, the two-compartment model is wrongly 
fitted by a tri-exponential equation for even very high SNR≈100 (Figure 3.3).  
 
  Exponential Model ADAPT Orders 
CSF:WM  ADC IVIM TRI (0,0) (1,0) (1,1) (2,0) (3,0) (3,1) 
100:0 
BICc -149 -144 -139 -152 -155 -150 -151 -153 -144 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 0 0.94 2.02 0.72 0 1.09 0.75 0.45 2.40 
75:25 
BICc -62 -100 -139 -56 -74 -89 -70 -66 -93 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 16.84 8.64 0 8.07 4.12 0.91 5.07 6.00 0 
50:50 
BICc -59 -97 -137 -57 -78 -93 -74 -69 -96 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 16.95 8.66 0 8.43 3.81 0.61 4.66 5.84 0 
25:75 
BICc -63 -105 -136 -64 -87 -103 -83 -77 -102 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 15.75 6.72 0 8.44 3.55 0 4.27 5.61 0.28 
0:100 
BICc -75 -129 -137 -78 -98 -120 -96 -91 -109 
𝐿𝐸𝑅𝐵𝐼𝐶𝑐 13.48 1.69 0 9.13 4.75 0 5.17 6.37 2.50 
The optimum fitting method for the PVE models (SNR≈ 50) was selected by 





The range of ADAPT orders from (0,0) to (3,3) were also applied to the PVE models (Table 
3.4).With the AICc, a distinct number of terms were found to be able to distinguish between 
two and three-compartment models. The two and three-compartment models were found to be 
best fitted by ADAPT orders (1,1) and (3,1) with no other competing order found to be 
significant. All other AICc-LERs were found to be >0.5, indicating that no other fit was 
Figure 3.3: Using the AICc-LERs, the number of compartments, identified by the multi-exponential 
fitting methods was investigated as a function of varying SNR in the PVE models. An AICc-LER<0.5 
indicated a competing model that needed to be considered. An AICc-LER>2 indicated a competing 
model that ‘definitely’ did not need to be considered. 
Figure 3.4: Using the AICc-LERs, the number of compartments, identified by the ADAPT method 
was investigated as a function of varying SNR in the PVE models. 
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statistically significant. The BICc results were found to be similar (Table 3.4), although 
ADAPT(1,1) was found to be a competing order (BICc-LER= 0.28) for the three-
compartment CSF:WM=25:75 signal. The one-compartment CSF model was best fitted by 
ADAPT(1,1) according to the AICc and ADAPT(1,0) with the BICc. Both list a range of 
different orders as the optimum fit, indicating that noise can easily corrupt a one compartment 
signal. The one-compartment signal was investigated at SNR≈100 and decisively found to be 
represented by ADAPT(0,0) (Figure 3.4), mathematically equivalent to the mono-exponential 
equation.  
Comparing the AICc values of the exponential and ADAPT fitting methods, for the one 
component signal, the AICc was lowest with ADAPT, indicating a better fit. However, the 
optimum AICc values are very similar and the RSS values are of the same order of magnitude 
(RSS for ADC = 1.2 ×10-5, ADAPT(0,0) = 1.5 ×10-5, ADAPT(1,1) = 4.0×10-6). For the three 
component signals, the tri-exponential fits have much lower AICc values than ADAPT(3,1). 
The RSS values are also two orders of magnitude smaller (i.e RSS for CSF:WM-50:50, TRI = 
4.3 ×10-5, ADAPT(3,1) =1.0 ×10-4). For the two-component data, the wrongly identified tri-
exponential fit has a very low RSS value (RSS for TRI  = 4.5 ×10-6, suggesting that the signal 
is being overfitted. Although the AICc for IVIM is still lower than ADAPT(1,1) (RSS for 
IVIM = 1.8 ×10-5, ADAPT(1,1) = 7.2 ×10-5), the RSS values are of the same order of 
magnitude, indicating a similar accuracy of fit.  
3.3.2.2 Number of ADAPT Components 
The transfer function, Z-transform, PFD and subsequent inverse Z-transform were performed 




3.3.3 SNR and Robustness of Data Simulations 
3.3.3.1 Influence of Noise upon the Tri-exponential Partial Volume Effects 
Model 
Using the AICc-LERs, the number of compartments identified by the multi-exponential fitting 
methods (Figure 3.3) and the ADAPT method (Figure 3.4) was investigated as a function of 
varying SNR. The multi-exponential fitting methods correctly identified the mono-
exponential behaviour in the PVE signal CSF:WM 100:0. However, the LER demonstrates 
that the optimum fit quickly becomes bi-exponential below the high SNR of 85. The three-
compartment PVE signals are best represented by the tri-exponential fit down to an SNR of 
35 for the CSF:WM of 75:25 and 50:50, and SNR 40 for 25:75. The PVE signal CSF:WM 
0:100 is incorrectly represented by a tri-exponential fit. This, however, becomes a bi-
exponential fit below SNR 50. CSF:WM 100:0 is best represented by the one component 
ADAPT(0,0) above an SNR of 75. Below SNR 75 the one component ADAPT(1,0), is the 
optimum order. However, ADAPT(2,0) and ADAPT(3,0) have AICc-LERs<0.5, indicating 
significant competing fitting methods. All three-compartment PVE models are best 
represented by the three-component ADAPT(3,1) down to an SNR of 45. For CSF:WM 
0:100, the optimum order is the two-component model ADAPT(1,1) down to an SNR of 45.  
Below this value the one component models and ADAPT (2,0), another two-component 
model, begin to show statistical significance. 
3.3.4 ADAPT Components Applied to Physical Phantom Acquisition 




Figure 3.5: Example case of the ADAPT method applied DWI axial slice of hydrogel phantom. a) 
DWI slice of phantom where b value=0 s/mm2. b) Apparent Diffusion Coefficient (ADC) parameter 
map of the phantom (mm2/s). c) ADAPT applied to the diffusion signal and the corresponding number 
of detected components are displayed. 
 
As indicated by the ADC (Figure 3.5b), the diffusivity of the hydrogels and water balloon are 
of the same order of magnitude. The ADAPT method detects one compartment in the 
hydrogels and water balloon (Figure 3.5c). However, at the interface between the water 
balloon and the gels, two-compartment behaviour was exhibited. 
3.3.5 ADAPT Components Applied to In-Vivo Data Acquisition 
The ADAPT method was applied to a DWI axial slice of both a volunteer and a patient case 
(Figure 3.6). Three ADAPT components were observed as a white line along the boundary of 
the ventricles for the volunteer case (Figure 3.6c). Such clusters of high order behaviour are 
consistent with partial volume effects. Few voxels exhibit one-component behaviour in the 
ventricles of the volunteer. This could be due to the limited size of the ventricles. A patient 
case was considered in which the ventricles were enlarged. Large clusters of one component 
behaviour were observed within the ventricles with some three-component behaviour also 




Figure 3.6: Example case of the ADAPT method applied to In-Vivo DWI axial slices. a) DWI 
slice of a volunteer where b value=0 s/mm2. b) DWI slice of patient with enlarged ventricles 
where b value=0 s/mm2 c) ADAPT applied to volunteer slice and the corresponding number 




3.3.6 ADAPT(1,1) Coefficient Study with Data Simulations 
The relationship between the ADAPT α and β coefficients, created as a result of minimising 
(Equation 3.2), and the IVIM f, D and D* parameters were investigated (Figure 3.7).  
 
Figure 3.7: The relationship between the ADAPT(1,1) coefficients and the IVIM parameters was 
investigated. a) Effects on the diffusion signal when only IVIM-D was varied and the other two IVIM 
parameters were fixed. b) Only IVIM-f varied. c) Only IVIM-D* varied. d) Linear relationship 






If IVIM-f and IVIM-D* are fixed, and only IVIM-D is varied for simulated data, the gradient 
of the detected diffusion signal can be observed to increase with an increasing IVIM-D value 
(Figure 3.7a).  An increase in the gradient of the signal would also increase the value of the 
ADAPT-β coefficients and result in a directly linear relationship between the IVIM-D and 
ADAPT(1,1)-β0 with R
2=1(Figure 3.7d). When IVIM-f and IVIM-D are fixed, increases in 
IVIM-D* result in a subtle increase in the gradient at the low b-values (Figure 3.7c). Such 
behaviour results in a linear correlation between IVIM-D* and the higher-order ADAPT(1,1)- 
β1 coefficient with R
2=0.99 (Figure 3.7f). When IVIM-D and IVIM-D* are fixed, and only 
IVIM-f is varied, an increase in IVIM-f results in an increase in the curvature of the bi-
exponential signal and the prevalence of the second component (Figure 3.7b). Consequently a 
linear relationship is found between IVIM-f and  ADAPT(1,1)-α1 with R2=0.99 (Figure 3.7e).  
 
Figure 3.8: Coefficient of Variation calculated for the coefficients of the optimum ADAPT and multi-
exponential fitting methods for each of the PVE models (SNR ≈ 50) considered. For the one-component 
model, CSF:WM=100:0, the ADC and ADAPT(0,0) fitting methods were implemented. For the two-
component models, CSF:WM=75:25,50:50 and 25:75, the tri-exponential and ADAPT(3,1) fitting 
methods were implemented. For the three-component models, CSF:WM=0:100, the tri-exponential and 
ADAPT(1,1) fitting methods were implemented. The IVIM method was also considered.  For each of 






The coefficients of ADAPT and the multi-exponential fitting methods were investigated for the 
PVE models (SNR≈50) (Figure 3.8).  For the one-compartment model, the optimum mono-
exponential fitting method and ADAPT(1,0) were considered. ADAPT(0,0) was also 
considered due to being mathematically equivalent to the mono-exponential equation. The CV 
was found to be 0.4% for the mono-exponential ADC and 0.2% for ADAPT(0,0)-β0. Both have 
a CV <1% indicating that both fitting methods were robust for fitting one compartment data. 
For ADAPT(1,0), β0 had a CV of 0.6% and α1 2735.7%. The β0 coefficients from ADAPT(0,0) 
and ADAPT(1,0) had a percentage variation of 0.0002%. Given the similarity in β0  coefficients 
and the high CV for ADAPT(1,0)-α1, it can be theorised that the additional parameter in the 
one component ADAPT(1,0) is a consequence of the noise added to the signal. For the three-
compartment models, the optimum fitting methods, ADAPT(3,1), and the tri-exponential fit 
were compared. In general, the ADAPT(3,1) coefficients have a lower CV than the tri-
exponential parameters. α2 and α3 have a higher CV than the TRI-fCSF and fWM parameters for 
the CSF:WM=50:50 case, but the CV is still less than 6.1%. For the CSF:WM=25:75 case, the 
TRI-fCSF had a CV of 13.2% significantly higher than any of the other parameters associated 
with three compartments. For the two-compartment model, ADAPT(1,1) was compared against 
both the bi- and tri- exponential fitting methods. Although selected as the optimum multi-
exponential fit, it is evident that the tri-exponential is the incorrect fit as the CV of TRI-fCSF is 
193.0%. Comparing the ADAPT(1,1) coefficients to the IVIM parameters, β0, β1, and α1 had 
CVs of 0.4%, 2.8% and 0.8% respectively. IVIM-D, IVIM-D* and IVIM-F were 0.3%, 2.2% 
and 2.9%. Both methods possessed low CVs for their parameters indicating that ADAPT(1,1) 
and IVIM are both robust fitting methods for two-compartment signals. 
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3.3.7 ADAPT(1,1) Coefficient Study with In-Vivo Data 
The ADAPT(1,1)-β0 (Figure 3.9b), α1 (Figure 3.9d) and β1 (Figure 3.9f) coefficients for an 
In-Vivo axial slice of a patient brain scan were correlated on a pixel-wise basis with the 
IVIM-D (Figure 3.9a), IVIM-f (Figure 3.9c) and IVIM-D* (Figure 3.9e) parameters 
respectively. Upon visual inspection, the IVIM-D and ADAPT(1,1)-β0 parametric maps 
Figure 3.9: Parametric maps of Axial  brain slice of patient with enlarged ventricles a) IVIM-D 




appear similar with the calibration bars also showing comparable scales. Furthermore, when 
the voxels with ADAPT(1,1) identified as the optimum order were selected (n=6002), 
s=0.708 (P <0.001) was obtained, indicating a strong relationship between IVIM-D and 
ADAPT(1,1)-β0. However, the edges of the ventricles appear to be affected by partial volume 
effects more in the IVIM maps than the ADAPT maps. IVIM-D* and ADAPT(1,1)-β1 were 
found to have an s= 0.741 (P<0.001), also indicating a strong relationship. The CPU run time 
of the IVIM fit for one slice was averaged over 10 iterations and found to be 575.0 ± 3.1 
seconds. Comparatively the CPU run time of ADAPT method was just 23.2 ± 0.1 seconds. 
The CV was calculated from the average coefficient values calculated from ROIs within the 
CSF and WM (Table 3.5). For the one compartment CSF, ADAPT(0,0)-β0 was almost identical 
to the ADC value and the CV <1.5%. For the two-compartment WM, ADAPT(1,1)-β0 was 
found to be the same order of magnitude as IVIM-D although the CV of IVIM-D was found to 
be just 4.6% compared to 10.7% for β0. However, ADAPT(1,1)-α1 has a lower CV than IVIM-
f 16.7% compared to 18.2%. ADAPT(1,1)-β1 has a significantly lower CV than IVIM-D*, 


















ADC 2.89E-03 4.04E-05 1.40 
(0,0)-b0 2.90E-03 3.73E-05 1.30 
2 
IVIM-D 8.66E-04 4.01E-05 4.64 
(1,1)-b0 6.24E-04 6.71E-05 10.77 
IVIM-D* 4.66E-02 3.67E-02 78.65 
(1,1)-b1 1.01E-03 2.53E-04 24.98 
IVIM-f 0.074 0.013 18.16 




ROIs were drawn within the WM and CSF on the patient axial slice (Fig. 5b). The parameter 





It has been demonstrated that the number of components in diffusion-weighted MRI data is 
determined unreliably by simply applying multi-exponential fitting methods and then 
selecting the optimum fit. For the simulations considered, the ADAPT method is superior at 
identifying multiple components. 
In the physical phantom, the ADAPT method was able to correctly identify bi-exponential 
behaviour at the interface between the two mono-exponential components. However, to 
recreate a partial volume effect exhibiting tri-exponential behaviour, a considerably more 
complex phantom, with flow effects, would be required. Consequently, the development of a 
physical phantom is beyond the scope of this thesis. 
In simulations, the ADAPT method also demonstrated that it could correctly identify the 
number of components in the bi-exponential signal across a large range of IVIM parameter 
values. The SNR analysis demonstrated that ADAPT was more robust at detecting both one 
and two-compartment signals.  
In simulations, ADAPT was superior at identifying three-component behaviour, even when 
the third component is more subtle, i.e. PVE model with CSF:WM 75:25.  However, the BICc 
did detect competing orders, indicating that the third compartment could be difficult to detect 
for cases where the fraction of CSF is more subtle. Although the tri-exponential fitting 
methods had lower RSSs than ADAPT(3,1) for the three-compartment PVE models, the low 
RSSs are more likely due to the study being culpable of the inverse crime (refer to section 3.5 
Study Limitations) and the tri-exponential fitting method being inherently biased towards the 
simulated tri-exponential data. Furthermore, the RSS values for the optimum ADAPT orders 
were still low, and the model selection was more robust. It is recommended that if the number 
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of compartments in a signal is unknown, the ADAPT method should be used instead of multi-
exponential fitting for model selection. 
ADAPT is a generalisation of exponential models and makes no prior assumptions about the 
number of components within the data. Thus ADAPT lends itself as a potential novel method 
for the detection of the number of components in DWI data. The data simulations indicated 
that there is a relationship between the IVIM parameters and ADAPT coefficients. A strong 
relationship between these two methods is also evident in the In-Vivo patient example. 
Although the relationship between the IVIM parameters and ADAPT coefficients is complex 
and non-linear, ADAPT presents the opportunity for complex diffusion biomarkers to be 
obtained by making no prior assumptions about the nature of the data nor does it require any 
multistep fitting processes. 
Consequently, in this study, ADAPT is a much faster fitting method. The In-Vivo ROIs 
showed that ADAPT(1,1) and IVIM had comparable parameter CVs. However, IVIM-D* was 
considerably higher. Although this may be due to tissue heterogeneity within the white 
matter, the average IVIM-D* value is higher than expected (111), indicating that ADAPT 
may be more robust than IVIM at fitting in WM.  
Both the ADAPT and multi-exponential fitting methods struggled to correctly identify the 
number of signal components at poor SNRs (< 45). The addition of noise to the tri-
exponential PVE models resulted in the methods under-fitting the signal. This was most likely 
due to noise modulating the true signal and causing individual components to be mistakenly 
classified together. The addition of noise to the mono-exponential fitting method resulted in 
overfitting the signal. Although ADAPT was still able to detect a one-component model at 
poor SNR, the optimum order, using the AICc, switched from ADAPT(0,0) to ADAPT(1,0) 
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resulting in an additional parameter.  Although more robust than the multi-exponential fitting 
methods, the ADAPT method requires further development to optimise how it handles low 
SNR data, and the inclusion of an additional component or parameter to account for noise 




3.5 Study Limitations 
In general, the AICc and BICc selected the same optimum order, increasing the confidence 
that the most appropriate order had been selected. However, a more formal protocol is 
required for when the information criterion methods disagree. 
One should note that only one range of clinically relevant b-values was considered for the 
data simulated or acquired In-Vivo in this study. The number of data points and their 
magnitude could have a significant influence on the performance of the ADAPT method and 
the generality of the findings. However, there is no clear consensus on what optimal b-value 
sequence should be used for DWI (199). As the ADAPT method requires a discrete 
approximation of the diffusion signal, there will inevitably be a truncation in the 
approximation, which is inherent to the method. Another limitation of the simulations in this 
study was the assumption that diffusion in the CSF exhibits mono-exponential behaviour, 
consequently the effects of CSF circulation or pulsatile flow (200) were not considered. 
However, such effects are assumed to have a minimal contribution to the observed signal. 
Given the limited spatial resolution, it is also difficult to ensure that choroid plexus does not 
contribute to voxels in close proximity. 
As far as the authors are aware, no other diffusion models with a perfusion fraction exist for 
simulating data other than the multi-exponential equations explored. Therefore it was not 
possible to avoid committing the ‘inverse crime’ (IC) where multi-exponential equations were 
used to simulate as well as fit the data. To mitigate the IC, Gaussian noise was added to the 
simulated data (201), and a range of different multi-exponential models were explored. In 
addition, the ADAPT method is a different mathematical model, and therefore the IC wasn’t 
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committed with this class of models. Hence the IC would more likely favour multi-
exponential fitting methods such as IVIM. 
The study only considered DWI data, which averages over all the directions in which a 
gradient is applied. Consequently, this method is only able to measure isotropic diffusion 
compartments. If anisotropic effects, such as fanning or crossing of axon bundles, were to be 
investigated, many diffusion-weighted images, with diffusion-weighted gradients in different 
directions, would be required resulting in Diffusion Tensor Imaging (DTI). Although multi b-
value models are not yet routine in clinical settings, it would be interesting to consider an 
application of ADAPT to this technique, in particular investigating anisotropic effects with 
further simulations and In-Vivo studies. 
Further investigations are required to understand how the number of optimum ADAPT 
components relates to the number of exponential terms within the signal. This is considered in 





The ADAPT method has shown that it can distinguish between multi-exponential diffusion 
data containing different numbers of components, which cannot be achieved by applying 
multi-exponential fitting methods and selecting the optimum fit. This novel method allows for 
the identification of different components within a diffusion signal. The relationship between 
the ADAPT and IVIM parameters suggest that diffusion biomarkers can be obtained without 
making prior assumptions about the nature of the data. Whilst ADAPT has been applied to 
DWI data; it should find application in other multi-exponential data sets which can be 












4. Correlation of Perfusion Effects in DWI with Perfusion MRI 
In this chapter, the coefficients of the ADAPT method and their relationship to perfusion 
information are further investigated. The correlation between the Dynamic Susceptibility 
Contrast (DSC), relative Cerebral Blood Volume (rCBV) and the ADAPT coefficients are 
investigated and compared to the correlation between rCBV and IVIM-f.  
4.1 Introduction 
Perfusion MRI uses techniques sensitive to cerebral haemodynamics in order to attain 
quantitative parametric maps. The most prevalent perfusion MRI technique used in clinical 
investigations is Dynamic Susceptibility Contrast (DSC) MRI (202). The  DSC parameter 
Cerebral Blood Volume (CBV), has demonstrable clinical value in the grading of gliomas 
(203), predicting tumour progression (204) and assessing treatment response (205). 
However, the routine use of DSC is confounded by the lack of consensus for an optimised 
DSC-MRI protocol (31) or for the gadolinium contrast agent injected (27). Furthermore, 
absolute quantification of parameters can be difficult to determine (28), and post-processing 
results can be user-dependent (22). There is some concern regarding the Gadolinium bolus 
(135). The use of some gadolinium contrast agents is restricted in some populations, such as 
young children (206). Recent studies have also found gadolinium deposits accumulating in 
patient’s brains and other organs after multiple injections of the contrast agent (136). Hence a 
contrast free method for measuring perfusion is desirable.   
Arterial Spin Labelling (ASL) is another perfusion MRI technique that is gaining considerable 
attention.  ASL doesn’t require an injectable contrast, instead relying on the labelling of 
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arterial blood as it flows through the brain. However, DSC has a higher signal to noise ratio 
(SNR) (33) and better temporal and spatial resolution (207). In addition, the image acquisition 
time of ASL protocols is significantly longer than that of DSC (22). 
Contrast free perfusion measurements may also be possible with Diffusion-Weighted Imaging 
(DWI). The Intravoxel Incoherent Motion (IVIM) model (90) is a bi-exponential equation 
with two components related to diffusion and perfusion-related measurements, respectively. 
The perfusion-related parameters, IVIM-D*; the pseudo-diffusion coefficient and IVIM-f; the 
volume fraction of flowing blood in the tissue, have been shown to be correlated with 
perfusion MRI parameters (42). Assuming the microvascular network is randomly orientated 
and isotropic, the relationship between IVIM-f and CBV is linear (208). 
Several studies have investigated the correlations between CBV and IVIM-f 
(38,111,120,138,140,209–212), with most reporting a moderate correlation (Federau et al. 
determined a Pearson’s r=0.59 in Gliomas (38), Kim et al. determined r=0.67 (P<0.001) in 
Glioblastomas (138)). Moderate correlations have also been reported in healthy tissue 
(Wirestam et al. r=0.56 (P<0.001) (212), Wu et al. r=0.29-0.48 in Grey Matter (111)). In 
contrast Bisdas et al. reported a negative correlative with Spearman’s rank, s=-0.57(P=0.09)  
in healthy tissue and s=-0.43(P=0.10) in Gliomas (140), although results were not significant. 
A poor correlation has been observed in regions of white matter (Wu et al. r=-0.02-0.05 
(111)). 
Across the correlation studies considered, variables that could impact the correlations are 
highly varied. The IVIM model is implemented with a range of different fitting methods 
(unconstrained and constrained with a multi-step approach) and different b-value 
distributions.  The effects of different IVIM fitting methods upon the correlation between 
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IVIM-f and CBV have previously been reported (212).The selection and size of the region of 
interest (ROI) is highly varied. The parameters, CBV and IVIM-f, are either fitted for the 
ROIs on a voxel-wise basis (140,209) or just for the signal average (120,212). The 
correlations are performed either voxel-wise for individual cases (111) or across the whole 
cohort taking the average (38), maximum (211) or 90th percentile (138) parameter values for 
each ROI. 
The choice of fitting method used to determine the IVIM parameters significantly affects the 
estimation of the IVIM-f parameter (121) and therefore, the correlation with CBV. The 
assumption of two-components by the  IVIM model could also affect the correlation with 
some diffusion models predicting multiple perfusion components within the diffusion signal 
(35). An alternative model for fitting multi-component diffusion signals is the Auto-
Regressive Discrete Acquisition Points Transformation (ADAPT) method. The ADAPT 
method is based on the Auto-Regressive Moving Average model (174), a generalised multi-
exponential model. ADAPT has the ability to represent a wide range of data sets and is not 
constrained to assume bi-exponential behaviour. The fitting method does not require any 
initial starting values or any multi-step fitting processes for robust parameters. ADAPT 
presents the opportunity for novel biomarkers to be obtained with no prior assumption about 
the nature of the data. In the previous chapter (Chapter 3), ADAPT(1,1) was shown to be the 
optimum ADAPT model for fitting bi-exponential behaviour (213). In addition, the parameter 
ADAPT(1,1)-α1 was shown to correlate strongly with IVIM-f.  
In this chapter, the correlation between rCBV (relative CBV, which has been normalised to 
white matter) and IVIM-f is investigated for a cohort of children with brain tumours (n=15). 
The correlation between rCBV and ADAPT(1,1)-α1 is also investigated and compared to the 
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correlation with IVIM-f. The impact of the number of components in the diffusion signal 




4.2 Materials and Methods 
4.2.1 Study Population  
Fifteen Paediatric brain tumour cases (5 Females, 10 Males, Age Range 1.6 – 10.3 years, 
Median 6.2 years) were considered for the evaluation of the correlation between rCBV and 
the DWI parameters (Table 4.1). Informed consent was obtained and the East Midlands – 
Derby Research Ethics Committee (REC 04/MRE04/41) approved the study operating under 
the rules of Declaration of Helsinki 1975 (and as revised in 1983). 
 







1 9.1 M Glioneuronal tumour 
2 5.8 F Optic pathway glioma 
3 6.5 M Optic pathway glioma 
4 4.1 M Optic pathway glioma 
5 6.5 F Ganglioglioma 
6 6.9 F Optic pathway glioma 
7 10.3 F Pilocytic Astrocytoma 
8 1.7 M Thalamic optic pathway glioma 
9 1.6 M Optic pathway glioma 
10 2.6 M Supratentorial low-grade glioma 
11 8.6 M Suprasellar pilomyxoid astrocytoma 
12 6.2 M Multisystem Langerhans Cell Histiocytosis 
13 3.3 M Optic pathway glioma 
14 6.2 F Optic pathway glioma 
15 5.0 M Ganglioglioma 
 
4.2.2 MRI Data Acquisition 
All patients were scanned on a Philips Achieva 3T TX (Philips Healthcare, Best, the 
Netherlands) MRI scanner at Birmingham Children’s Hospital using a 32-multichannel 
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receiver head coil. A T2-weighted TSE scan was performed using the following parameters: 
FOV 240mm x 240mm, TR/TE 4000/100ms, matrix size 288×288, 30 slices with 3.5mm slice 
thickness and in-plane resolution 0.9mm × 0.9mm. 
The Diffusion-weighted MRI sequence, acquired with the same coverage as the T2 scan, used 
a sensitivity-encoded (SENSE) approach with single-shot, spin-echo (EPI) sequence and the 
following parameters:  FOV 240mm x 240mm, TR/TE 4000/91ms, matrix size 96×96, 30 
slices with 3.5mm slice thickness and in-plane resolution 2.5mm × 2.5mm. A b-value 
sequence of 11 exponentially spaced b-values between 0 and 1000 s/mm2, [0, 20, 40, 80, 110, 
140, 170, 200, 300, 500, 1000] s/mm2, was acquired in three orthogonal directions. The scan 
duration of the diffusion protocol was 2.12 minutes.  
The DSC protocol was performed following the DWI protocol and was acquired with the 
same coverage as the T2 and the DWI scan. The FOV and image resolution of the DSC 
protocol was identical to that of the DWI protocol.  The DSC scan was an axial FE-EPI scan 
with the parameters: TR/TE 1865/40ms, flip angle 20° and temporal resolution 1.86s, which 
was repeated 60 times. The gadolinium contrast agent (Dotarem, Guerbet, Frace) was 
administered via a power injector through a cannula inserted in an antecubital vein. The dose 
was administered in two stages; the first dose was administered before the DSC acquisition as 
a pre-bolus to minimise T1 effects (214). The second dose was administered at the start of 
time point 5 in the DSC data acquisition. The total dose of contrast agent given was 0.1 
mmol/kg with an injection rate of 3 mL/s. Each dose was subsequently followed by a saline 
injection at the same rate, up to 10mL dependent on the patient’s weight. 
4.2.3 Data Analysis 





= 𝑓 ∙ exp (−𝑏𝐷∗) + (1 − 𝑓) ∙ exp (−𝑏𝐷) (4.1)  
Where S(b)/S(0) is the signal intensity of the normalised signal for a particular b-value; 
IVIM- D is the diffusion coefficient; IVIM-D* is the pseudo-diffusion coefficient; and IVIM-
f is the volume fraction of incoherently flowing blood in the tissue describing the fraction of 
the signal arising from the vascular network (36). The IVIM model was fitted to the diffusion 
scans using a non-linear least-square fitting, and a constrained one-parameter fitting method 
(121). This model assumes that the effects of perfusion are negligible in measurements at high 
b-values.  For b-values > 200 s/mm2, a monoexponential fitting method is implemented. By 
plotting the signal on a logarithmic scale and calculating the gradient and y-intercept, IVIM-D 
and IVIM-f can be calculated respectively. The fitting method was applied on a voxel by 
voxel basis.  
The ADAPT equation is given as (Equation 4.2): 
ln(𝑆𝑛) = ∑ 𝛽𝑖𝑏𝑛−𝑖
𝑄
𝑖=0 + ∑ 𝛼𝑗𝑙𝑛(𝑆𝑛−𝑗)
𝑃
𝑗=1  (4.2)  
Where Sn is the signal at acquisition point n, bn is the b-value at acquisition point n, and αj, βi 
are the minimisation coefficients. At each acquisition point, the signal value can be modelled 
as a linear combination of the previous b-values and corresponding signal values. The 
parameters P and Q indicate the number of previous terms that the input signal depends upon. 
The ADAPT order ADAPT(1,1) was considered (Equation 4.3): 
ln(𝑆𝑛) = 𝛽0𝑏𝑛 + 𝛽1𝑏𝑛−1 + 𝛼1𝑙𝑛(𝑆𝑛−1) (4.3)  








































































              
Where S is a matrix constructed from the b-values and the detected signal with acquisition 
point n=0, …, N. A is the matrix of ADAPT coefficients. Spred is the final model of the 
normalised predicted signal. By finding the least-squares error of Equation 4.4, A is minimised, 
and the model Spred is established:  
 
𝑆 ∙ 𝐴 = 𝑆𝑝𝑟𝑒𝑑 (4.5) 
 
The ADAPT method was used to determine the number of components. A range of ADAPT 
orders from ADAPT(0,0) to ADAPT(3,3) were fitted to each diffusion signal. The optimum fit 
was selected using the corrected Akaike Information Criterion (AICc) (173).ADAPT orders 
between ADAPT(0,0) and ADAPT(1,0) identified signals with one component, between 
ADAPT(1,1) and ADAPT(2,2) identified two component signals and between ADAPT(3,0) 
and ADAPT(3,3) identified three component signals (213). 
The rCBV parametric map was derived from the DSC scan. The tracer tissue concentration-
time course data was obtained from the signal-time course data by considering the relationship 
between the tracer tissue concentration and the T2* signal intensity. By considering the area 
below the tracer tissue concentration-time course, the rCBV value was attained with arbitrary 
units mL/100 mL. Leakage corrections were applied using preload-dosing and baseline 
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subtraction techniques, further details of the method can be found in J. Novak and S. Withey 
et al. (215). 
Tumour regions of interest (ROI) were drawn manually on the T2-weighted images (Average 
Tumour ROI=461 ± 243 voxels). Areas of cyst were excluded from the ROIs. Grey Matter 
(GM) and White Matter (WM) masks were created using the Brain Extraction Tool (BET) (216) 
and the FMRIB’s Automated Segmentation Tool (FAST) (217) from the FMRIB Software 
Library v6.0 (Analysis Group, Oxford, UK) using the T2-weighted images. A probability map 
was generated predicting whether a voxel was WM, GM or cerebrospinal fluid (CSF). WM and 
GM masks were created, using only voxels with a 100% probability of being that tissue type. 
To further mitigate the effects of partial volumes, an image erosion of 1 voxel was applied to 
each mask. The Tumour ROI, areas of cyst and CSF were masked out with an additional 
exclusion of 2 voxels around these areas- (Average GM ROI=4999 ± 1654 voxels, Average 




Figure 4.1: Example of Region of Interests (ROIs) drawn for each tissue type considered in the 
correlation study. a) T2 axial slice of the whole brain. b) grey matter selected, c) white matter selected, 
d) tumour selected. 
 
 
4.2.4 Statistical Analysis 
For each of the cases in the study population, the correlation analysis between rCBV and 
IVIM-f was assessed using Spearman’s rank correlation coefficient. The correlation between 
rCBV and ADAPT(1,1)-α1 was also considered. The two correlations were directly compared 
across the whole brain and GM, WM and Tumour ROIs.  A summary statistic for the cohort 
was established by considering the correlation across all cases. The average correlation for 
each ROI was determined by implementing the Fischer-Z transformation (35) to normally 
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distribute the correlation coefficients. As the correlations to compare are dependent and 
overlapping, Zou’s 95% confidence intervals were calculated with lower and upper bounds to 
assess if one correlation was statistically stronger than the other (36). The mean, median and 
standard deviation were also calculated for each parameter across all voxels in each of the 




4.3.1 rCBV, IVIM-f and ADAPT(1,1)-α1 Parameter Comparison  
Parametric maps of rCBV, IVIM-f and ADAPT(1,1)-α1 were calculated on axial slices from 
the cohort (Figure 4.2). 
 
Figure 4.2: Example parameter maps for the perfusion measurements: a) axial b0 image of Optic 
pathway Glioma case and corresponding parameter maps b)DSC-rCBV, c) IVIM-f, d)ADAPT(1,1)-
α1, e)axial b0 image of Suprasellar pilomyxoid astrocytoma and corresponding parameter maps 
f)DSC-rCBV, g) IVIM-f, h)ADAPT(1,1)-α1 
  
 
Upon visual inspection, the parametric maps appear similar with the calibration bars for the 
diffusion measurements showing comparable scales. 
Spearman’s rank was calculated on a voxel-wise basis for each of the cases across the whole 
brain and GM, WM and Tumour ROIs. The Spearman’s rank correlation is reported for each 





Table 4.2: Spearman’s Rank correlations between DWI measurements and rCBV for each case in the 
cohort considering the whole brain. P < 0.001 for all measurements. 
Whole Brain 















1 0.471 0.574 0.830 33823 -38.24  -0.11 -0.10 ADAPT(1,1)-α1 
2 0.440 0.456 0.917 32749 -7.77 -0.02 -0.01 ADAPT(1,1)-α1 
3 0.413 0.456 0.922 36647 -23.13 -0.05 -0.04 ADAPT(1,1)-α1 
4 0.262 0.485 0.731 38503 -64.95  -0.23 -0.22 ADAPT(1,1)-α1 
5 0.447 0.422 0.698 37560 7.10 0.02 0.03 IVIM-f 
6 0.584 0.576 0.968 34649 6.92 0.01  0.01 IVIM-f 
7 0.404 0.336 0.936 26655 33.16 0.06 0.07 IVIM-f 
8 0.451 0.589 0.892 35982 -64.34 -0.14 -0.13 ADAPT(1,1)-α1 
9 0.403 0.471 0.868 39494 -29.18 -0.07  -0.06 ADAPT(1,1)-α1 
10 0.463 0.503 0.868 44628 -18.73  -0.04  -0.03 ADAPT(1,1)-α1 
11 0.398 0.610 0.833 36024 -78.31 -0.22 -0.21 ADAPT(1,1)-α1 
12 0.704 0.672 0.965 27078 27.66 0.03 0.04 IVIM-f 
13 0.502 0.597 0.910 31745 -46.65 -0.10  -0.09 ADAPT(1,1)-α1 
14 0.529 0.576 0.949 35955 -33.34 -0.05  -0.04 ADAPT(1,1)-α1 
15 0.277 0.387 0.857 37089 -42.00 -0.11  -0.10 ADAPT(1,1)-α1 
 
Significant correlations were achieved in all cases with moderate correlations observed between 
rCBV and IVIM-f (s= 0.277-0.704, P<0.001) and rCBV and ADAPT(1,1)-α1 (s=0.336-0.672, 
P<0.001). Strong correlations were observed between the diffusion measurements IVIM-f and 
ADAPT(1,1)-α1 (s=0.731-0.968, P<0.001). As determined by Zou’s confidence interval, the 
correlation between rCBV and ADAPT(1,1)-α1 was statistically stronger than the correlation 
between rCBV and IVIM-f in 11 of the 15 cases considered.  
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The Spearman’s rank correlations for each of the cases are shown for all of the tissue types 
considered in Figure 4.3. In the GM ROIs, ADAPT(1,1)-α1 had the strongest correlation to 
rCBV in 12 of the 15 cases, IVIM-f had a stronger correlation to rCBV in one case, and for two 
cases the correlations were determined to be of statistically comparable strength. For the WM 
ROIs, in relation to rCBV, ADAPT(1,1)-α1 had the statistically stronger correlation in 9 cases, 
IVIM-f in 5 cases and for one case the correlations were determined to be of statistically 
comparable strength. For the Tumour ROIs, in relation to rCBV, ADAPT(1,1)-α1 had the 
statistically stronger correlation in 7 cases, IVIM-f in 2 cases and for 6 cases, the correlations 
were determined to be of statistically comparable strength. 
 
Figure 4.3: Spearman’s Rank correlations between DWI measurements and rCBV for each case in the 






Considering the average correlation across the whole cohort (Table 4.3), the correlation 
between rCBV and ADAPT(1,1)-α1(s=0.520, P<0.001) was determined to be statistically 
stronger than the correlation between rCBV and IVIM-f (s=0.433, P<0.001).  For the average 
Spearman’s rank correlation, the correlation between rCBV and ADAPT(1,1)-α1 was 
statistically stronger across GM, WM and Tumour ROIs for the whole cohort.  
 
Table 4.3: Spearman’s Rank DWI measurements and CBV for the different tissue types. The Average 
and total correlations across the cases are reported, P < 0.001 for all measurements. 
















Whole Brain 0.433 0.520 0.897 35238 -40.72 -0.09 -0.08 ADAPT(1,1)-α1 
Grey Matter 0.557 0.578 0.929 4999 -4.82 -0.03 -0.04 ADAPT(1,1)-α1 
White Matter 0.401 0.425 0.898 5719 -4.43 -0.03 -0.01 ADAPT(1,1)-α1 
Tumour 0.520 0.568 0.892 460 -2.66 -0.08  -0.01 ADAPT(1,1)-α1 
Total 
Whole Brain 0.397 0.471 0.712 491735 -77.42 -0.08 -0.07 ADAPT(1,1)-α1 
Grey Matter 0.506 0.521 0.768 60134 -6.71 -0.02 -0.01 ADAPT(1,1)-α1 
White Matter 0.395 0.419 0.697 74384 -9.22 -0.03 -0.02 ADAPT(1,1)-α1 
Tumour 0.480 0.649 0.807 4254 -21.28 -0.19 -0.15 ADAPT(1,1)-α1 
 
The average correlations for each region of interest considered were statistically stronger 
between rCBV and ADAPT(1,1)- α1  than between rCBV and IVIM-f across the cohort.  
Between rCBV and ADAPT(1,1)- α1, Spearman’s rank, s=0.520, 0.578, 0.425, 0.568 and 
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between rCBV and IVIM-f, s=0.433, 0.557, 0.401, 0.520  (P<0.001) across the whole brain and 
regions of grey matter, white matter and tumour respectively. 
Spearman’s rank correlations were also considered on a voxel-wise basis across every case 
(Total Correlation, Table 4.4). Considering the Spearman’s rank, rCBV had a statistically 
stronger correlation with ADAPT(1,1)-a1 than with IVIM-f for all ROIs considered. Between 
rCBV and ADAPT(1,1)- α1, Spearman’s rank, s=0.471, 0.521, 0.419 and 0.649 and between 
rCBV and IVIM-f, s=0.397, 0.506, 0.395, 0.480 (P<0.001) across the whole brain and regions 
of grey matter, white matter and tumour respectively.  
The voxel-wise parameter values were correlated for an axial slice from one of the cases and 
plotted in Figure 4.4. The strongest correlations were observed in GM; the correlations in the 
Tumour appeared to have the greatest variability. For the rCBV and IVIM-f correlations, the 





Figure 4.4: Parameter values for each voxel of an axial slice from a patient in the cohort. Correlations 
between (left) rCBV and IVIM-f and (right) rCBV and ADAPT(1,1)-α1. Correlations in regions of 
(top-bottom) Grey Matter, White Matter, Tumour and across the Whole Brain. 
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The parameter mean, median, and standard deviation for each tissue type, calculated across all 
voxels in the cohort, are presented in Table 4.4.  
 
Table 4.4: Mean, Median and Standard Deviation of rCBV, IVIM-f, ADAPT(1,1)-α1 parameters for 
the cohort across different tissue regions on a voxel-wise basis. 
 Grey Matter White Matter Tumour Whole Brain 
 rCBV IVIM-f ADAPT-α1 rCBV IVIM-f ADAPT-α1 rCBV IVIM-f ADAPT-α1 rCBV IVIM-f ADAPT-α1 
Mean 4.73 0.12 0.66 2.89 0.10 0.62 2.80 0.21 0.7 3.24 0.12 0.68 
Median 3.76 0.10 0.68 2.61 0.08 0.63 2.44 0.14 0.71 3.03 0.1 0.69 
Std Dev. 3.60 0.07 0.16 1.63 0.06 0.14 2.79 0.21 0.23 1.63 0.1 0.18 
  
The rCBV parameter exhibits the greatest variability. rCBV measurements were respectively 
highest in GM. IVIM-f and ADAPT(1,1)-α1 measurements were higher in GM than WM but 
respectively highest in Tumour ROIs. For all parameters, variability was greatest in the Tumour 
ROIs. 
4.3.2 Number of DWI Components and the Impact on Perfusion 
Measurements 
The optimum ADAPT order was selected for each voxel, and thus the number of components 
in the diffusion signal determined (Figure 4.5). Most of the brain was determined to exhibit 
two-component behaviour; areas of one component behaviour were exhibited within the 
ventricles (Figure 4.5.b). Three-component behaviour was detected near the boundary of the 
ventricles (Figure 4.5.b and 4.5.d), indicating potential partial volume effects. Three-
component behaviour was also exhibited within some tumour ROIs (Figure 4.5.f); this could 





Figure 4.5: Example case of the ADAPT method applied to In-Vivo DWI axial slices. a)  Axial b0 
image, enlarged ventricles, b) ADAPT component map. c) Axial b0 image, enlarged ventricles and 
low perfused tumour, d) ADAPT component map, e) Axial b0 image, high perfused tumour, f) 
ADAPT component map. 
 
The correlations were then performed voxel-wise within the regions identifying as one-, two- 
and three-component behaviour respectively. Spearman’s rank was then calculated for the 






Table 4.5: Average Spearman’s Rank correlations between DWI measurements and rCBV for each 
case in the cohort considering the whole brain. One, Two and Three-component diffusion signals 
considered (determined with the ADAPT method) P < 0.001 for all measurements. 
 Spearman’s Rank (s)   Zou's 95% CI  















Whole Brain- Average 
1 0.133 0.239 0.840 1969 -8.49 -0.13 -0.08 ADAPT(1,1)-α1 
2 0.457 0.505 0.890 30378 -20.87 -0.05 -0.04 ADAPT(1,1)-α1 
3 0.380 0.511 0.860 467 -5.94 -0.18 -0.09 ADAPT(1,1)-α1 
 
Regardless of the number of components detected, the correlation between rCBV and 
ADAPT(1,1)-α1 was statistically stronger than the correlation between rCBV and IVIM-f. Both 
correlations were moderate in regions that exhibited two components within the diffusion signal 
(rCBV and IVIM-f: s=0.457, rCBV and ADAPT(1,1)-α1: s=0.505, P<0.001). In regions of 
three-component behaviour, the correlation between rCBV and ADAPT(1,1)-α1 was 
comparable to the respective correlation in two components (rCBV and ADAPT(1,1)-α1: 
s=0.511, P<0.001)  and the correlation between rCBV and IVIM-f was weaker (rCBV and 
IVIM-f: s=0.380, P<0.001). Both correlations were weakest in regions that exhibited one 
component behaviour (rCBV and IVIM-f: s=0.133, rCBV and ADAPT(1,1)-α1: s=0.239, 
P<0.001). The ratio of one-, two- and three-component voxels was 3:96:1 in GM, 4:94:1 in 
WM and 14:84:2 in tumours. 
4.3.3 High Order ADAPT behaviour  
For the voxels identified as exhibiting three-component behaviour, a higher-order ADAPT 
model, ADAPT(3,1), was fitted to the diffusion signal. The parameter ADAPT(3,1)-α1 was 
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correlated against rCBV (s=0.641, P<0.001) demonstrating a stronger correlation than IVIM-f 





Average correlations were statistically stronger between rCBV and ADAPT(1,1)-α1 than 
between rCBV and IVIM across the cohort. Both of these diffusion models are two component 
models. The ADAPT model makes no prior assumption about the diffusion signal and does not 
require multi-step fitting, a key factor that may contribute to the stronger correlation with rCBV. 
A significant correlation was reported between rCBV and IVIM-f in the Tumour and GM ROI 
across the paediatric cohort. These results are in agreement with respective correlation studies 
in the adult population (18–21,23,25).  A significant correlation was also found for the WM 
ROIs, not previously reported (25). 
The Spearman’s rank correlations between rCBV and ADAPT(1,1)-α1 were significantly 
stronger than the correlations between rCBV and IVIM-f for all tissue types considered across 
the cohort. It is evident that the correlation between rCBV and ADAPT(1,1)-α1 is non-linear 
(Figure 4.4). This is due to the ADAPT method fitting the logarithm of the diffusion signal, as 
this provides greater parameter stability (37). Pearson’s r correlation coefficient would be 
unsuitable for investigating this non-linear correlation (38). A transformation could be applied 
to the ADAPT(1,1)-α1 data to ensure a linear correlation. However, given the properties of 
logarithms, if a linear summation of parameters is fitted to a logarithm of linear components, 
the relationship between the fitted parameters and original components cannot be recovered. 
Hence the transformation to ensure a linear correlation would be empirical. As the Spearman’s 
rank correlation remains unchanged by any monotonic transformation (39), it is the 
recommended correlation coefficient to assess the correlations considered here. 
The correlation of the diffusion parameters to rCBV was affected by the number of components 
detected in the diffusion signal. The correlation with voxels identifying one component 
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behaviour was weakest. Theoretically, these voxels have no perfusion component, or a 
perfusion fraction too small to be currently detected.  Hence, voxels with one component 
behaviour should be excluded from perfusion studies. The ADAPT method could be used to 
potentially identify voxels with such behaviour (29). 
The correlations with voxels identifying two or three components were comparable for the 
ADAPT method. In voxels with three component behaviour, the parameter ADAPT(3,1)-α1 
demonstrated an even stronger correlation with rCBV than ADAPT(1,1)-α1 or IVIM-f. The 
correlation between rCBV and IVIM-f in voxels with three components was comparatively 
weaker, highlighting another breakdown of the IVIM model’s two-component assumption. This 
suggests that with more complex diffusion models, a better understanding of the perfusion 
behaviour could be attained. Three-component behaviour could, however, be caused by a 
multitude of reasons, such as partial volume effects (27)(40). Different ADAPT coefficients 
could potentially represent different flow regimes. Other ADAPT coefficients related to three-
component behaviour should also be investigated. The correlations in tumour ROIs were 
moderate despite the heterogeneity. For the tumour correlations considered in each of the 15 
cases, 6 cases were unable to determine which correlation was statistically stronger. This is 
likely due to the small size of the tumours and consequently small ROIs unable to provide the 
statistical power. With a larger cohort, the difference in correlations between low- and high-
grade tumours could be investigated. 
The mean IVIM-f parameter measurements were higher in GM (0.12 ± 0.07) than they were in 
WM (0.10±0.06), in agreement with previous studies (25)(41). However, the parameter values 
were slightly higher than some of those previously reported in adult correlation studies, 
particularly for white matter (Wu et al. IVIM-fGM=0.14 ± 0.02, IVIM-fWM=0.07 ± 0.01(25), 
Grech-Sollars et al. IVIM-fGM=0.10 ± 0.002, IVIM-fWM=0.08 ± 0.002). This could be explained 
118 
 
by the increase in perfusion reported in children compared to adults (42). The standard deviation 
of our results was higher, but this is likely due to considerably larger ROIs than other studies. 
In Tumour ROIs, the median IVIM-f was considerably higher than in healthy tissue 
(0.21±0.21). The high variance was likely due to tumour heterogeneity and the different tumour 
types included within the cohort. Within the tumour voxels, 14% were identified as exhibiting 
one component behaviour. As the IVIM equation is a bi-exponential model, the IVIM-f 
parameter could be wrongly estimated in these instances, further contributing to the high 
parameter variance. Although there are relatively twice as many three-component voxels in 
tumour ROIs compared to ROIs in healthy tissue, the overall number of three-component voxels 
is still comparatively small. This suggests that overestimation of IVIM-f is more likely caused 
by the one-component voxels instead of partial volume effects.  
The mean rCBV parameter measurements were higher in GM (4.73±3.36 mL/100 mL) than 
WM (2.89±1.63 mL/100 mL). The grey matter values were comparable to those previously 
reported, but the measurements in white matter were considerably higher (Wu et al. IVIM-
rCBVGM=4.4±0.5 mL/100 mL, rCBVWM=0.07±0.01 mL/100 mL (25)). The discrepancies and 
greater variation are most likely attributed to the age of the cohort and number of voxels 
considered, but also the different fitting methods implemented for DSC data (43). The rCBV 
tumour measurements had the greatest variation (2.30 ± 2.79 mL/100 mL) and is attributed to 
the heterogeneity of tumours and the different types considered within the cohort. There is a 




4.5 Study Limitations 
There are some limitations to the work presented in this chapter. The distribution of b-values 
in the DWI sequence could change the performance of the two diffusion models considered. 
For the GM and WM, the ROIs were not manually drawn. In previous studies, considerably 
smaller ROIs were manually drawn, resulting in a lower variance. The correlations were also 
enhanced by deliberately selecting voxels that exhibited high IVIM-f values (21). The 
application of such methods to this work could have further increased the correlations observed. 
Although DSC and DWI were acquired with the same image resolution, the sequential 
acquisition could result in patient movement between scans contributing to voxel mismatches. 
Fluctuations in noise could further affect the correlations.  
As with any correlation analysis, a fundamental relationship cannot be proven by the results of 
a correlation study. Furthermore, the biophysical relationship between rCBV and the ADAPT 
parameters is unknown. ADAPT is based on the Auto-Regressive Moving Average model, 
which is considered atheoretical (45). However, the α1 parameter has been shown to relate to 
the decay rate of an exponentially decaying signal (46). For a DWI signal, increased perfusion 
will result in a fast signal decay rate. Although the relationship between the ADAPT parameters 
and the rCBV measurement is complex and non-linear in nature, ADAPT presents the 
opportunity for complex perfusion biomarkers to be obtained by making no prior assumptions 





The ADAPT coefficients have a greater correlation than the IVIM-f parameter with rCBV 
measured by DSC-MRI. The moderate correlations observed demonstrate that perfusion 
information can be obtained non-invasively through diffusion measurements. The ADAPT 
method makes no prior assumptions about the number of exponential components contributing 
to the data, which gives it an advantage over the IVIM fitting method, which inherently assumes 
two-component behaviour. Complex multi-component diffusion and perfusion information 
exists within the DWI signal. To probe and understand this rich information, a highly sensitive 











5. The ADAPT Method for Parameter Selection 
In this chapter, the ADAPT method is reformulated, and the IVIM parameters are fully 
derived from the ADAPT coefficients. The ADAPT fitting method is compared to the multi-
step, non-linear, least-square fitting algorithm commonly used to estimate the IVIM 
parameters, with a particular focus on the IVIM-D* parameter. Both fitting methods 
investigate simulated white matter and grey matter brain models, considering the accuracy, 
precision and bias for a range of Signal to Noise Ratio (SNR) levels. Once optimised, the 
performance of the fitting methods is investigated in In-Vivo data.  
5.1 Introduction 
The Intravoxel Incoherent Motion (IVIM) method requires multiple b-values to measure 




= 𝑓 ∙ 𝑒𝑥𝑝−𝑏𝐷
∗
+ (1 − 𝑓) ∙ 𝑒𝑥𝑝−𝑏𝐷 (5.1) 
Where S(b)/S(0) is the signal intensity of the normalised signal for a particular b-value (a 
parameter that is changed by varying the diffusion sensitization of the MR sequence); IVIM- D 
is the diffusion coefficient; IVIM-D* is the pseudo-diffusion coefficient (related to the 
perfusion of blood in the capillary network); and IVIM-f is the volume fraction of incoherently 
flowing blood in the tissue describing the fraction of the signal arising from the vascular 
network (36).The IVIM method assumes the detected signal is comprised of two exponentially 
decaying compartments; with decay constants equal to IVIM- D and IVIM-D*. The effects of 
IVIM-D* are most evident in the acquired signal at the very low b-values (b < 100 s/mm2) 
(102), as values of IVIM-D* are typically several orders of magnitude higher than IVIM-D 
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(37). The perfusion-related parameters IVIM-f and IVIM-D* have demonstrated clinical value 
in diagnosing diseased tissue, such as liver fibrosis (114) and deteriorating renal function in the 
kidneys (107), and in the grading of tumours (218). Correlations between IVIM-D* and the 
microvascular density in histology samples have also been reported (219). 
Despite the additional perfusion-related information available with IVIM-D*, this parameter is 
not yet routinely calculated. Compared to the other IVIM parameters, IVIM-D* has the largest 
measurement error (111,120), high heterogeneity (111,220,221), poor reproducibility (45,191) 
and is difficult to evaluate (102). Consequently, several IVIM reproducibility studies have only 
considered IVIM-D and IVIM-f (191,222,223), or even questioned the clinical applicability of 
IVIM-D*, particularly in low perfused tissues such as the brain (191,220). 
The estimation of IVIM-D* is dependent upon the diffusion-weighted MR sequence, the 
number of b-values and the fitting method implemented. Parameter estimation can be 
confounded by the inherent assumption of two tissue compartments in the IVIM model. For 
example, in regions that are cystic or ischemic with no perfusion compartment, IVIM-D* is not 
defined. In such a case, IVIM-D* can be incorrectly assigned the same value as IVIM-D (120). 
IVIM-f will then be estimated by any value between 0 and 1, evidently increasing parameter 
variability. If more than two-compartments are present, such as partial volume effects between 
brain tissue and cerebral spinal fluid (CSF), the high diffusion coefficient of CSF can be 
misinterpreted and be incorrectly measured in the IVIM-D* parameter. Other bulk flow 
phenomena, such as tubular flow or glandular secretion (128), may also contribute to the signal 
(102). Furthermore, the range of physiologically possible IVIM-D* values is much greater than 
for the other IVIM parameters, increasing the parameter variance (224). 
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For IVIM-D*, low perfused tissues have a higher measurement error due to the weakly bi-
exponential signal (45). An increase in the number of b-values, sampling more of the low b-
value regime, has been shown to increase parameter robustness (116). However, the b-value 
sequence implemented can influence parameter estimation, causing bias (117,225). To increase 
stability in the parameter estimations, IVIM is typically fitted using a constrained, Multi-Step 
approach. IVIM-D* is estimated via a nonlinear, least-squares fitting method, once IVIM-D 
and IVIM-f have been estimated (121,226). IVIM-D and IVIM-f are fitted using b-values above 
a selected threshold (typically b-values > 200 s/mm2) at which the perfusion effects are 
considered negligible. However, this threshold is postulated to be tissue-dependent and will 
influence the estimation of IVIM-D* (37). Any errors in the fitting of IVIM-D and IVIM-f will 
propagate and increase the error in IVIM-D*. Compared to unconstrained fitting, the Multi-
Step method reduces variability but consequently has a higher parameter bias. A range of 
different fitting methods for the IVIM parameters have been considered (45,125), but there is 
not yet a consensus on the best processing approach. 
Hence there is a need to develop improved analysis methods for fitting DW-MRI data if the 
routine clinical use of IVIM-D* is to be attained. In this chapter, the Auto-Regressive Discrete 
Acquisition Points Transformation (ADAPT) method was implemented for the recovery of the 
IVIM parameters. The ADAPT method is based on a non-stationary, special case of the auto-
regressive moving average model (227), a generalised multi-exponential model. ADAPT 
interprets the diffusion signals as a discrete function of acquisition points where the behaviour 
of the signal can be derived from the relationship between these acquisition points. ADAPT can 
represent a wide range of data sets and is not constrained to assume bi-exponential behaviour. 
ADAPT does not require any Multi-Step fitting processes, initial starting values, nor the 
oversampling of low b-values for robust parameter estimation (213).  
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The ability for ADAPT to correctly identify the number of components was established in a 
previous chapter (Chapter 3) and a strong correlation between the ADAPT coefficients and 
IVIM parameters confirmed. In previous chapters (Chapter 3 and Chapter 4), the ADAPT 
method was applied to a logged DWI signal. However, in this chapter the ADAPT method is 
applied to a normalised DWI signal with an offset of -1 (resulting in a signal value of 0 at b=0 
s/mm2), allowing the ADAPT coefficients to derive the IVIM parameters directly. The 
performance of the ADAPT fitting method is compared with the Multi-Step, non-linear, least-




5.2 Materials and Methods 
5.2.1 The Auto-regressive Discrete Acquisition Points Transformation  
The ADAPT method was modified to model the diffusion signal by the equation (Equation 
5.2):   






Where Sn is the signal at acquisition point n, bn is the b-value at acquisition point n, and αj, βi 
are the minimisation coefficients. Here the acquisition point of the b-values is used such that b 
value=0 s/mm2 is at acquisition point 0. The subsequent b-value in the sequence would be 
acquisition point 1. At each acquisition point, the previously acquired b-values and signal 
values are used as previous input terms. Hence the signal at acquisition point n can be modelled 
by a linear summation of previous b-values and signal values. The parameters P and Q indicate 
the number of lag terms that the input signal depends upon. Upon selecting the order of the 
ADAPT(P,Q) model, the α and β minimisation coefficients are determined by minimising the 
normal equation. The ADAPT method uses the normalised diffusion signal, with an offset of -
1 to ensure that that at acquisition point 0, the output, Sn-1, is 0. This is required so that for the 
first few data points, where the ADAPT order is greater than the acquisition points, a value of 
0 can be substituted for cases where bn−i or Sn−j don’t exist. The αj, βi coefficients are established 
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Where S is a matrix constructed from the b-values and the detected signal with acquisition point 
n=0, …, N. A is the matrix of ADAPT coefficients. Spred is the final model of the normalised 
predicted signal. By finding the least-squares error of Equation 5.4, A is minimised, and the 
model Spred is established:  
𝑆 ∙ 𝐴 = 𝑆𝑝𝑟𝑒𝑑 (5.4) 
5.2.1.1 Determining the Number of Components with ADAPT 
Once the optimum ADAPT(P,Q) order has been selected, the number of components in the 
signal can be determined using the transfer function. The transfer function is given by dividing 
the signal output, (Sn-1), by the signal input, (bn). Equation 5.2 can be rearranged as (Equation 
5.5): 
(𝑆𝑛 − 1) − 𝛼1(𝑆𝑛−1 − 1) −⋯− 𝛼𝑃(𝑆𝑛−𝑃 − 1) = 𝛽0𝑏𝑛 + 𝛽1𝑏𝑛−1 +⋯+ 𝛽𝑄𝑏𝑛−𝑄 (5.5) 
Using the Lag Operator, Equation 5.5 can be re-written as (Equation 5.6): 
(𝑆𝑛 − 1)(1 − 𝛼1?̂? − ⋯− 𝛼𝑃?̂?




Where ?̂? is the Lag Operator(181) such that ?̂?(𝑆𝑛 − 1) = (𝑆𝑛−1 − 1). Hence the transfer 





𝛽0 + 𝛽1?̂? + ⋯+ 𝛽𝑄?̂?
𝑄
1 − 𝛼1?̂? − ⋯− 𝛼𝑃?̂?𝑃
 (5.7) 
By performing a Z-transform on the transfer function, converting the discrete signal to a 






1 − 𝛼1𝑧−1 −⋯− 𝛼𝑃𝑧−𝑃
 (5.8) 
Providing P ≥ Q, finding the poles of the system, that is, the number of roots for the 
denominator of Equation 5.8 when equated to zero, yields the number of components. For 
example, ADAPT(2,2) gives (Equation 5.9): 
(𝑆𝑛 − 1) = 𝛼1(𝑆𝑛−1 − 1) + 𝛼2(𝑆𝑛−2 − 1) + 𝛽0𝑏𝑛 + 𝛽1𝑏𝑛−1 + 𝛽2𝑏𝑛−2 (5.9) 








−2  (5.10)  
Here the denominator is a quadratic expression with two roots. Consequently, ADAPT(2,2) is 
evaluated to be a two-component decay model. The number of components is determined by 
the Pth order of the optimum ADAPT(P,Q) model.  
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5.2.1.2 Deriving the IVIM parameters with ADAPT 
The IVIM method models a bi-exponential diffusion signal (Equation 5.1). To derive the IVIM 
parameters from the ADAPT coefficients, the Z-transform for the sum of P exponentials is 





Where S[n] is the measured signal at acquisition point n; P is the number of exponential terms; 
fi indicates the amplitude of each exponential term; Dj is the decay constant, and b[n] gives the 
b-value at n. If the b-value sequence is linearly spaced with incremental gaps of Δb, then b[n] 






;     where 𝑟𝑗 = exp(−𝐷𝑗∆𝑏) (5.12) 







By equating the denominators of the Z-transforms of the ADAPT equation (Equation 5.8) and 










It can be inferred that the poles, xj, of Equation 5.8 will also be solutions to the denominator in 










Hence the multi-exponential decay constants can be derived from the poles of the optimum 





5.2.2 Data Simulations 
All simulations and data analysis were conducted using MATLAB (MathWorks, Natick, MA, 
USA, v.2017b). Diffusion signals were simulated using the IVIM equation in Equation 5 .1. 
White Matter (WM) and Grey Matter (GM) models were simulated using IVIM parameters 





-3mm2/s; fGM=0.14) (111). The ADAPT 
method requires linearly spaced b-values in order to derive the IVIM parameters. A series of 
clinically relevant, linearly spaced b-value sequences between 0 and 1000s/mm2 were 
investigated with the number of b-values ranging between 7 and 16. Non-linearly spaced b-
value sequences, optimised for IVIM, were also used for simulations, with a sequence of 11 
exponentially spaced b-values [0, 20, 40, 80, 110, 140, 170, 200, 300, 500, 1000] and an 
optimised sequence of 16 b-values [0, 40, 50, 60, 150, 160, 170, 190, 200, 260, 440, 550, 
600, 700, 980, 1000] considered. The 16 b-value sequence was proposed by Lemke et al. (45) 





5.2.3 Robustness Analysis 
The robustness of the fitting methods was investigated with the addition of random white 
Gaussian noise to the simulations to mimic different levels of SNR. Although the noise in 
DWI is governed by a Rician distribution, it is well approximated by a Gaussian distribution 
for the SNR levels considered in this simulation (73). The lowest SNR level considered was 
40, a typical value recorded for DWI measurements in previous studies (45)(121) and also in 
the In-Vivo case considered. SNR levels of 57, 69, 80, 89, 98, 106, 113 and 120 were also 
considered as these correspond to the SNR levels when the number of signal averages 
(NSAs) are linearly increased. When the NSA doubles, the SNR is increased by a factor of 
√2. The SNR level added to the diffusion signal was uniform across the b-values. The data 
simulations were performed using 1000 random data iterations for each model and SNR 
level. 
5.2.4 In-Vivo Data Acquisition 
To validate the performance of the fitting methods In-Vivo, a volunteer brain scan (age 26 
years), was scanned on a Philips Achieva 3T TX (Philips Healthcare, Best, the Netherlands) 
MRI scanner at Birmingham Children’s Hospital using a 32-multichannel receiver head coil. 
Informed consent was obtained and the East Midlands – Derby Research Ethics Committee 
(REC 04/MRE04/41) approved the study operating under the rules of Declaration of Helsinki 
1975 (and as revised in 1983). The diffusion-weighted MRI sequence used a sensitivity-
encoded (SENSE) approach with single-shot, spin-echo (EPI) sequence and the following 
parameters: b-value data acquired in three orthogonal directions, FOV 230mm x 230mm, 
TR/TE 3214/84ms, matrix size 256x256, 5mm slice thickness and in-plane resolution 0.9mm 
x 0.9mm. A b-value sequence of 11 linearly spaced b-values between 0 and 1000 s/mm2, [0, 
100, 200, …, 1000] s/mm2, was used. The scan duration of this protocol was 2.12 minutes. 
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The patient was scanned with the above protocol 8 successive times, with a dynamic scan, 
(duration 16.94 minutes) in order to assess the reproducibility of the IVIM parameters and to 
increase the signal to noise ratio (SNR) by averaging over the repeated measurements.  
5.2.5 Data Analysis 
A range of ADAPT orders from ADAPT(0,0) to ADAPT(3,3) were applied to the simulated 
diffusion signals with the optimum ADAPT order chosen by using the corrected Akaike 
Information Criterion (AICc) for model selection in finite data sets (173). The AICc, selects 
the optimum model by rewarding models for their goodness of fit and penalising for the 
number of parameters in the model. This penalty term discourages overfitting, and the model 
with the lowest AIC is deemed the optimum model (Equation 5.17):  




2 ∙ 𝑘 ∙ (𝑘 + 1)
𝑛 − 𝑘 − 1
 (5.17) 
Where n is the number of b-values, RSS is the residual sum squared, and k is the number of 
model parameters. The diffusion signal, S0 is included as a model parameter, and an 
additional parameter is counted due to the Gaussian noise hypothesis for signal residues. The 
optimum fit relative to the other considered models is justified by using Bayes Factors (193). 
The associated statistic, the log evidence ratio (LER) indicates the evidence for a competing 
model being the true optimum fit against that selected by the AICc. LER values greater than 
0, 0.5, 1 and 2 indicate that a competing model has ‘minimal’, ‘substantial’, ‘strong’ or 
‘decisive’ evidence that it is not the optimum fit. 
The IVIM fitting method was assessed using non-linear least-square fitting, and a constrained 
one-parameter fitting method (121). This model assumes that the effects of perfusion are 
negligible in measurements at high b-values.  For b-values > 200 s/mm2, a monoexponential 
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fitting method is implemented. By plotting the signal on a logarithmic scale and calculating 
the gradient and y-intercept, IVIM-D and IVIM-f can be calculated respectively. These 
parameters are given to Equation 5.1 and IVIM-D* is found using the with the Levenberg-
Marquardt algorithm with the result bound between 0 and 5×10-2mm2/s (219) This fitting 
method is henceforth referred to as the Multi-Step method.  
The ADAPT method and Multi-Step method were fitted to the brain tissues models and also 
In-Vivo volunteer data. SNR levels for the In-Vivo measurements were calculated for the 
WM and GM using 5 4x4 pixel ROIs from each tissue type. The SNR of each ROI was 
calculated from the pixel-wise standard deviation across the multiple acquisitions (228). In-
Vivo GM and WM masks were created using the Brain Extraction Tool (BET) (216) and the 
FMRIB’s Automated Segmentation Tool (FAST) (217) from the FMRIB Software Library 
v6.0 (Analysis Group, Oxford, UK) using the T1-weighted images. A probability map was 
generated predicting whether a voxel was WM, GM or cerebrospinal fluid. WM and GM 
masks were created, using only voxels with a 100% probability of being that tissue type. To 
further mitigate the effects of partial volumes, an image erosion of 1 voxel was applied to 
each mask. 
 
5.2.6 Statistical Analysis 
To determine the optimal b-value sequence to implement with the ADAPT method, the 
simulated sequence that returned the lowest total relative error for the WM and GM models 












Where N is the number of iterations, xi is the fitted parameter result for the ith iteration, and x 
is the true parameter value. The total relative error was found by summing the relative errors 
for each of the 3 IVIM parameters; σTOT=σD+σD*+σf. 
For the model simulations, accuracy was assessed by comparing the mean parameter values 
measured by the fitting methods to their true values. The difference between the fitted 
parameter result and the true value was also measured using the relative bias, θx. for 









Precision was assessed by calculating the coefficient of variation (CV) over the 1000 
iterations measured. For all accuracy and bias measurements, significance tests were 
performed using Analysis of variance (ANOVA) and the Tukey post hoc analysis (P < 0.05). 
For the In-Vivo data, the average IVIM-D* parameter and CV were calculated from the ROIs 
in the WM and GM and investigated for both fitting methods. To investigate the distribution 






5.3.1 ADAPT Method for Model Selection  
A range of ADAPT orders were fitted to GM and WM models.  The diffusion signals were 
simulated with a range of different SNR levels (Table 5.1).   
  




The ADAPT method for model selection was found to be robust down to SNR≈57, with 
ADAPT(2,2), a two-component model determined to be the optimum fit. SNR≈40 was found 
to incorrectly determine the number of compartments in WM, which agrees with previous 
work(213). At SNR≈40, the GM simulations had ADAPT(2,1), also a two-component model, 
as their optimum fit. For WM simulations at SNR≈40, ADAPT(3,1), a three-component 
model, was found to be the optimum fit, indicating that noise was misinterpreted as an 
additional component. For SNR ≥ 80 no other orders competed with ADAPT(2,2) for either 
the WM or GM models with all LERs > 0.5. ADAPT orders (0,0), (1,0), (2,0), and (3,0) were 
Two component White Matter and Grey Matter diffusion models were investigated with a range of b-values and Signal to 
Noise Ratio (SNR) levels. The ADAPT method was applied to the bi-exponential signals and the optimum fit 
(highlighted in dark grey) was selected by choosing the method with the lowest AICc. Those ADAPT orders lightly 
shaded have an LER<0.5, indicating competing models. 
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also considered but had comparatively higher LER values. Sequences with 9, 11 and 13 b-
values with SNR levels 40, 57, and 80 are shown in Table 5.1 and are indicative of the results 
found for other b-value sequences and SNR levels. Due to the model selection performance, 
simulations at SNR≈40 were not considered any further. 
5.3.2 Optimum ADAPT sequence  
The relative error for the IVIM-D* parameter and the total relative error was calculated for 
the WM and GM signals across the range of linearly spaced b-value sequences and SNR 
levels considered. The optimum number of b-values was found to be 11 for all SNR levels 
considered having the lowest total relative error and lowest relative error for the IVIM-D* 
parameter (Figure 5.1). 
 
Figure 5.1: Relative error for the ADAPT method deriving the IVIM parameters as a function of the 
number of linearly spaced b-values in the signal. The relative error for the D* parameter in a) white 
matter, b) grey matter, Total relative error for all IVIM parameters in c) white matter, d) grey matter. 
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The optimum b-value sequence for ADAPT was [0, 100, 200, 300, 400, 500, 600, 700, 800, 
900, 1000] s/mm2. However, it can be noted that the ADAPT model is stable for the b-value 
sequences with 9 to 13 equally spaced b-values. In WM, at SNR≈57, σTOT was minimised 
with an 11 b-values sequence, σTOT=2.206. However, σTOT was comparable for 10 and 12 b-
value sequences with σTOT = 2.351 and 2.285, respectively. At even higher SNR levels the 
minima found at 11 b-values was negligible; in WM, at  SNR≈120,  σTOT =0.013, 0.012 and 
0.013  for 10, 11, and 12 b-value sequences respectively.  
5.3.3 Model Data Simulations 
5.3.3.1 Parameter Variability 
The WM and GM simulation results for estimating IVIM-D, IVIM-D* and IVIM-f with the 
ADAPT method for an 11 b-value sequence linearly spaced are compared to the parameter 
results derived by the Multi-Step method with the 11 b-values linearly spaced, 11 b-values 




Figure 5.2: Accuracy results for the estimated IVIM parameters from the data simulations using the 
different fitting methods. WM models: a) IVIM-D, b) IVIM-D* c)IVIM-f. GM models: d) IVIM-D, e) 
IVIM-D* f)IVIM-f. The dashed lines represent the true IVIM parameter values, and the error bars the 
standard deviation for the 1000 iterations. 
  
 
At high SNR levels, the ADAPT method provided more accurate IVIM parameters, in 
relation to the parameter averages of the 1000 iterations. This is most notable for IVIM-D* 
where ADAPT is the most accurate fitting method for WM with SNR ≥ 69, and GM with 
SNR ≥ 80. For IVIM-D, ADAPT becomes the most accurate fitting for WM with SNR ≥ 106 
and GM with SNR ≥ 98, For IVIM-f, ADAPT becomes the most accurate at SNR ≥ 106 for 
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WM and SNR ≥ 98 for GM. The error bars for all IVIM parameters derived by the ADAPT 
method were, however larger in comparison to those obtained by the Multi-Step method. 
For all IVIM parameters, the measurements obtained by the ADAPT method compared to all 
those obtained by the Multi-Step method (and various distributions of b-values considered) 
were significantly different (ANOVA P<0.001) with the ADAPT estimations closest to the 
ground truth values (Tukey P<0.05). This was across both the WM and GM models and all 
SNR levels considered with the only exception being IVIM-f in WM at SNR ≈ 69 and 80. 
With the Multi-Step Method, comparing the IVIM parameter measurements obtained with the 
different distributions of b-values, there was no significant difference in IVIM-D or IVIM-f 
(P > 0.05) for SNR ≈ 57, 69 and 80 for either the WM or GM models. IVIM-D* had a 
significant difference across all SNR levels (P < 0.05) and all IVIM parameter measurements 
were significantly different (P< 0.05) for SNR ≥ 113. 
The CV for all IVIM parameters fitted by the Multi-Step method for the three distributions of 
b-values considered were < 10% for the WM and GM models at SNR ≥ 57. As the Multi-Step 
method is typically fitted using an exponentially spaced sequence, the results for the CV, 
relative error and relative bias are shown using both the 11-linearly and 11-exponentially 
spaced b-value sequences in the figures below. However, the 11-linearly spaced method has a 
lower relative error and relative bias for both the WM and GM across all SNR levels 
considered. Consequently, only the results from the 11 linearly spaced b-value distribution 
are discussed any further. 
The CV for all IVIM parameters was greater when fitted with the ADAPT method than with 





Figure 5.3: Coefficient of Variation (%) calculated for the fitting of the IVIM parameters with 
the ADAPT method and the multi-step fitting method for 11 equally spaced linear b-values. 
WM models: a) IVIM-D, b) IVIM-D*, c) IVIM-f. GM models: d) IVIM-D, e) IVIM-D*, f) 
IVIM-f. The dashed lines represent a CV=10%. 
 
 
Although the parameter CVs are greater for the ADAPT fitting method, the CV is <10% for 
the WM in IVIM-D, IVIM-D* and IVIM-f at SNR ≥89, 80, 106, and in GM, SNR ≥ 89, 69, 98 
respectively. The relative error was calculated for each of the IVIM parameters along with a 




Figure 5.4: Relative Error calculated for the fitting of the IVIM parameters with the ADAPT method and the Multi-Step fitting method for 
11 equally spaced linear b-values. WM models: a) IVIM-D, b) IVIM-D*, c)IVIM-f, d) Total.GM models: e) IVIM-D, f) IVIM-D*, 
g)IVIM-f, h) Total. 
 
  





Table 5.2: Relative Error (± standard deviation) of IVIM parameters from White Matter and Grey 
Matter brain models fitted with the Multi-Step and ADAPT fitting method 
 
For SNR≈57, the relative error in the IVIM-parameters for both the WM and GM models is at 
least an order of magnitude greater with the ADAPT model than with the Multi-Step method. 
However, as the SNR level increases, ADAPT begins to outperform the Multi-Step method. 
The performance is most notable for the IVIM-D* parameter. By SNR≈69, the relative error 
in the WM is comparable; σD∗=0.128, 0.189 for the Multi-Step method and the ADAPT 
fitting method respectively. 
For SNR≈89, σD∗ is considerably smaller for the ADAPT fitting method in the WM model; 
σD∗=0.127, 0.013 for the Multi-Step method and the ADAPT fitting method respectively. As 
the SNR level increases, the relative error for the Multi-Step method plateaus while the 
relative error for the ADAPT fitting methods continues to decrease; i.e. at SNR≈120 in the 
WM model, σD∗=0.1271, 0.0004 for the Multi-Step and ADAPT fitting method respectively. 
In the GM model, ADAPT has a smaller σD∗ from SNR≈80. The ADAPT method gives a 




smaller relative error for the other IVIM parameters at high SNR levels: from SNR≈106 and 
SNR≈98 for the IVIM-D parameter in the WM and GM respectively; from SNR≈113 and 
SNR≈106 for the IVIM-f parameter in the WM and GM. By SNR≈98, the total relative error 
in both the WM and GM is smallest when parameters are fitted using the ADAPT method 
instead of the Multi-Step method. 
5.3.3.2 Parameter Bias 
The relative bias results for the IVIM parameters in the WM and GM tissue models are 
presented in Figure 5.5. In general, the relative bias was positive for IVIM-D and IVIM-D* 
and negative for IVIM-f. For the IVIM parameters fitted by the Multi-Step method, the 
relative bias in each of the parameters appeared unchanged across the range of SNR levels 
considered. Higher biases were apparent in the perfusion related parameters, IVIM-D* and 
IVIM-f for the WM model, a lower perfused model compared to the GM. Conversely, the 
relative bias of the parameters derived by the ADAPT method were varied across the SNR 
levels considered, with the relative bias decreasing by orders of magnitude as the SNR 
increased.  





Figure 5.5: Relative Bias (absolute values) calculated for the fitting of the IVIM parameters with the 
ADAPT method and the Multi-Step fitting method for 11 equally spaced linear b-values. WM model: 
a) IVIM-D, b) IVIM-D*, c)IVIM-f. GM model: d) IVIM-D, e) IVIM-D*,f)IVIM-f. 
  
 
For the WM model, θD∗ >10% (SNR≈120, θD∗=12.71 ± 0.003%). From SNR≈80, the ADAPT 
method outperforms the Multi-Step method in the WM model, with θD∗=0.80 ± 0.04% 
compared to θD∗=12.73 ± 0.32%. The same trend was observed for θD∗ in the GM (Table 5.3). 
In the WM, ADAPT has a lower relative bias from SNR≈89, 69, 89, for the IVIM-D, IVIM-
D* and IVIM-f parameters, respectively. For the GM the threshold is at SNR≈80 for all three 
parameters. For the 11 exponentially spaced b-values, in WM, at SNR≈120, θD∗=32.54 ± 
0.004%). The relative bias for IVIM-D* in WM was also investigated using the 
unconstrained fitting method (where all IVIM parameters are simultaneously fitted); at 
SNR≈120, θD∗=6.05 ± 0.00024% and θD∗=7.15 ± 0.0028% with 11 exponentially and 11 
linearly spaced b-values respectively. 




Table 5.3: Relative Bias (%) of IVIM parameters 
  
5.3.4 In-Vivo Data Analysis 
For the In-Vivo data, averaged over 8 acquisitions, the SNR at b-value=1000s/mm2 was 
found to be 122.8±27.9 in the WM ROIs and 138.1±18.9 in the GM. The IVIM-D* parameter 
maps, calculated with the ADAPT and Multi-Step fitting methods for an axial slice, are 
presented in Figure 5.6. 
 
 
Figure 5.6: a)DWI axial volunteer slice where b=0 s/mm2, averaged over 8 acquisitions. b)IVIM-D* 
parameter map calculated using the multi-step method. C) IVIM-D* parameter map calculated using 
the ADAPT method. 
  
In the WM, the average IVIM-D* value was reported as D*WM=7.7×10
−3 ± 5.7×10−4 mm2/s, 
CV=7.33% and D*GM=10.3×10
−3 ± 5.6×10−4 mm2/s, CV=5.43% for the ADAPT and the 
Multi-Step methods respectively. In the GM, D*GM=9.2×10
−3± 5.2×10−4 mm2/s, CV=5.70% 





−3± 5.4×10−4 mm2/s, CV=5.55% for the ADAPT and the Multi-Step 
methods. The WM and GM histograms are presented in Figure 5.7.  
 
Figure 5.7: Histograms of IVIM-D* for In-Vivo data fitted with the multi-step and ADAPT fitting 
methods. White Matter region of interest (n=2687) and Grey Matter region of interest (n=1327). 
 
 
The ADAPT method exhibited a broader histogram curve, implying greater variance in 
measuring IVIM-D*, in comparison to the Multi-Step method.  The histogram peaks were at 
higher IVIM-D* values for the multi-step method in both the WM and GM. 
  





At high SNR levels, the ADAPT method is the superior fitting method, with a lower relative 
error and relative bias for each of the IVIM parameters considered.  With the Multi-Step 
method, relative bias does not improve with increasing SNR levels and is incapable of 
yielding an accurate IVIM-D* in most situations. The bias in the estimated parameter values 
is strongly related to the b-value distribution (116). This is most evident in the IVIM-D* 
parameter. With the multi-step method, low perfused tissues require oversampling of the 
diffusion signal in the ‘low b-value’ regime (b < 200s/mm2) (102)(104) in order to detect the 
subtle behaviour. Consequently, this oversampling means that any non-linear b-value 
sequence will bias the parameter fitting, as observed with the 11 exponentially spaced b-value 
sequence. 
The Multi-Step method had a strong negative bias on all the IVIM-f values indicating that 
this method under fits the IVIM-f parameter and consequently overestimates the IVIM-D* 
parameter. The relative bias for IVIM-D* is greatest in the WM model, as this has a lower 
perfusion than the GM model. Even at SNR≈120, the bias of the Multi-Step method is >10% 
(12.71 ± 0.13%) in the WM model. The relative bias of the unconstrained fitting method was 
also greater than in the ADAPT method. 
The ADAPT fitting method was successfully implemented for the In-Vivo case, with a small 
CV(<10%) observed in the WM and GM. Although the parameter bias couldn’t be measured, 
as the ground truth is unknown, the trends are the same as those observed in the simulations. 
The average IVIM-D* value is greater with the Multi-Step method, and the histograms have 
peaks at higher IVIM-D* for the Multi-Step fitting method, supporting the observation that 
the Multi-Step method overestimates IVIM-D*. 




It is recommended that providing the SNR level is sufficiently high (SNR ≥ 80) the ADAPT 
method should be used for recovery of the IVIM-D* parameter. However, an even higher 
SNR level is required for the stable recovery of the IVIM-D and IVIM-f parameters with the 
ADAPT method (SNR ≥ 98). As many IVIM studies don’t consider IVIM-D*, if IVIM-D and 
IVIM-f are the only two parameters of interest, then the Multi-Step method should be 
implemented. For IVIM-D and IVIM-f, the Multi-Step method is robust from SNR≈40 with 
the CV and relative bias <10%. 
  




5.5 Study Limitations 
Although the ADAPT method can attain a greater precision and accuracy, the time taken to 
achieve such a high SNR could be challenging in a clinical setting. If such a high SNR level 
is not feasible to attain, then a hybrid method for parameter recovery could be possible. At 
SNR≥80, using the equally spaced b-value sequence, the ADAPT method could be used to 
attain IVIM-D*. The same diffusion signal could then be fitted with the Multi-Step method 
to estimate IVIM-f and IVIM-D. As the ADAPT method makes no prior assumptions about 
the diffusion signal nor requires Multi-Step fitting procedures, it is a much faster fitting 
algorithm (213).  
It may be seen as a limitation that the ADAPT method requires the b-values to be equally 
spaced. This is a b-value sequence unlikely to be used in current IVIM protocols. However, 
non-linearly spaced b-value sequences are currently required due to the poor fitting of 
IVIM-D*. The Multi-Step method requires the oversampling of the perfusion regime and is 
thus intrinsically biased. The ADAPT method requires a substantially higher SNR level 
than the Multi-Step method for parameter estimation, highlighting the general limitations of 
parameter estimation from noisy data. Regardless of the number of b-values or model used, 
no fitting method can truly give accurate and precise parameters with noisy data (229).  
Other IVIM fitting methods should also be compared to the ADAPT method. i.e. Bayesian 
probability methods (125,230). Bayesian analysis doesn’t require initial parameter 
estimations. However, the implementation of such a method can be computationally 
intensive and parameter estimations greatly influenced by the prior information specified. 
Additionally, the low variability observed in parameter estimations may be at the expense 
of masking features in heterogeneous tissue (231). 




The ADAPT method should be further developed to optimise fitting data with low SNR 
levels. The effects of denoising algorithms (232) should also be explored for the potential to 
avoid long acquisition times. The inclusion of an additional parameter or compartment to 
model the noise should also be considered. 
  





At high SNR levels, the ADAPT method can successfully derive the IVIM parameters from 
the diffusion signal without making any prior assumptions about the nature of the data. The 
ADAPT method can estimate IVIM-D* with an acceptable relative bias and more accuracy 











Conclusions and Future Work 
  




6. Conclusions and Future Work 
6.1 General Overview 
The Auto-regressive Discrete Acquisition Points Transformation (ADAPT) method was 
developed for the estimation of multicomponent diffusion and perfusion behaviour within 
biological systems. The ADAPT method demonstrated that it could correctly identify the 
number of multiexponential components within the diffusion signal. This is something that 
cannot be achieved by applying multi-exponential fitting methods and selecting the optimum 
fit. This is an essential technique as the number of components within the diffusion signal 
greatly affects parameter estimations and consequently, the interpretation of the data. The 
coefficients of the ADAPT method also demonstrated a significant correlation with the 
Intravoxel Incoherent Motion (IVIM) parameters and the Dynamic Susceptibility Contrast 
(DSC) derived cerebral blood volume, highlighting a non-invasive method to obtain perfusion 
information. The ADAPT method and respective coefficients could be used to fully interpret 
the diffusion and perfusion measurements. 
Alternatively, the diffusion signal could instead be interpreted though multiexponential decay 
constants via a reformulation of the ADAPT method. Providing the b-values in the diffusion 
sequence are equally spaced, the IVIM parameters can be mathematically derived from the 
ADAPT coefficients. The ADAPT method can estimate the IVIM parameters with lower bias 
and more accuracy than currently implemented fitting methods, which inherently provide 
biased values of the parameters. This is of particular significance for the perfusion IVIM-D* 
parameter which is not yet routinely calculated due to poor measurement errors with current 
fitting methods.  The technical validation of the ADAPT method, both in component detection 
and parameter estimation, demonstrated that such techniques were robust and could be 




implemented with In-Vivo data, but highlighted the need for a sufficiently high signal to noise 
ratio and spatial resolution within the data. In this thesis, it has been demonstrated that multi b-
value DWI data contains complex diffusion and perfusion information. With more advanced, 
sensitive techniques, such as the ADAPT method, this information can be probed further and 
establish a deeper understanding of tissue structure and behaviour. 
Final conclusions and suggestions for the direction of future studies are presented below: 
  




6.2 Final Conclusions 
1. The ADAPT method demonstrated the ability to robustly fit a variable number of 
components and identify voxels exhibiting partial volume effects. IVIM parameter 
estimation is confounded in regions of partial volume effects, resulting in the 
thresholding of diffusion data in and around the ventricles. Hence the ADAPT method 
could be used to recover useful diffusion and perfusion related parameters from 
information that would otherwise be discarded. Technical validation demonstrated that 
the identification of the components was robust. 
2. The ADAPT coefficients were shown to correlate with the perfusion measurement 
Dynamic Susceptibility Contrast- relative Cerebral Blood Volume (rCBV). The 
correlation was statistically stronger than the correlation between IVIM-f and rCBV. As 
DWI is a non-invasive method, this work highlighted a bolus free method for obtaining 
perfusion information. The performance of ADAPT also demonstrated that the fitting 
method used for interpreting the diffusion signal could greatly impact the correlation 
performance.  
3. The ADAPT method was reformulated to enable the derivation of the IVIM model 
parameters from the ADAPT coefficients.  The ADAPT fitting method was compared 
to the Multi-Step fitting method commonly used for IVIM parameter estimation. 
Considering the technical validations required for a quantitative imaging biomarker, the 
IVIM parameter accuracy and bias was lower with the ADAPT method. These results 
demonstrate that the ADAPT method was demonstrated to accurately measure IVIM-
D* at high signal to noise ratio (SNR) levels. Unlike the Multi-Step method, the ADAPT 
method attained an acceptable relative bias for the IVIM-D* parameter. Providing the 




SNR is sufficiently high (SNR ≥ 80); the ADAPT method should be used for the 
recovery of the IVIM-D* parameter.  
  




6.3 Limitations and Future Works 
1. The physical meaning of the ADAPT coefficients requires further investigations. 
Although the IVIM parameters can be mathematically derived from the ADAPT 
coefficients, error propagation will result in the IVIM parameters being less robust than 
the ADAPT coefficients. Hence the biophysical meaning of each of the ADAPT 
coefficient should be established in order to allow their direct interpretation. This should 
be explored through a range of studies, including establishing relationships with other 
perfusion biomarkers and further investigating computational models. A physical flow 
phantom should also be considered for validating perfusion measurements. 
2. The ADAPT method should be further developed to optimise fitting data with lower 
SNR levels. In particular, the effects of denoising algorithms in combination with 
ADAPT should be explored for the potential to avoid long acquisition times. Selection 
of the optimum denoising algorithm is non-trivial and would require a considerable 
investigation. The inclusion of an additional component or parameter to account for 
noise should also be considered in future developments of the ADAPT method. 
3. The ADAPT method for IVIM parameter extraction requires a linearly spaced b-value 
sequence for estimation of the IVIM parameters. This is a b-value sequence unlikely to 
be used in current IVIM protocols. However, current fitting methods require the 
oversampling of the low b-values in order to measure the effects of perfusion and are 
consequently intrinsically biased. ADAPT provides a method for robust component 
detection and parameter estimation, making no prior assumptions about the nature of 
the data.  
4. With technical advancements, higher quality diffusion data can be attained, and the 
parameters from more complex multiexponential equations could be investigated. The 




feasibility and robustness of parameters relating to a tri-exponential model should be 
explored. The ADAPT method should also be used to explore anisotropic effects with 
Diffusion Tensor Imaging (DTI). Such a study would require extensive considerations 
for the number of b-values and number of directions to include in the protocol.  The 
ADAPT method would require reformulation and further interpretation of the resulting 
optimum ADAPT order. The trade-off between SNR and scan duration would also need 
to be considered. Although applications to DTI signals require extensive work, such 
work would enable anisotropic effects such as fanning or crossings of axon bundles to 
be explored. Further simulations and In-Vivo studies should be investigated. 
 
The work in this thesis highlights the pitfalls of the assumptions and biases made by current 
multi b-value diffusion fitting methods. A new fitting method was investigated to address these 
pitfalls and evaluated. ADAPT could potentially obtain complex diffusion and perfusion 
biomarkers. Rich multicomponent information is present in the DWI signal.  In order to extract 
this complex tissue behaviour, the ADAPT method is recommended for the fitting of multi b-
value DWI data. 
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